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Despite the accepted health benefits of consuming
dietary fiber, little is known about the mechanisms
by which fiber deprivation impacts the gut micro-
biota and alters disease risk. Using a gnotobiotic
mouse model, in which animals were colonized with
a synthetic human gut microbiota composed of fully
sequenced commensal bacteria, we elucidated the
functional interactions between dietary fiber, the
gut microbiota, and the colonic mucus barrier, which
serves as a primary defense against enteric patho-
gens. We show that during chronic or intermittent
dietary fiber deficiency, the gut microbiota resorts
to host-secreted mucus glycoproteins as a nutrient
source, leading to erosion of the colonic mucus
barrier. Dietary fiber deprivation, together with a
fiber-deprived, mucus-eroding microbiota, pro-
motes greater epithelial access and lethal colitis by
the mucosal pathogen, Citrobacter rodentium. Our
work reveals intricate pathways linking diet, the gut
microbiome, and intestinal barrier dysfunction,
which could be exploited to improve health using
dietary therapeutics.
INTRODUCTION
The diet of industrialized nations has experienced a decrease in
fiber intake, which for many is nowwell below the recommended
daily range of 2835 g for adults, and this deficit has been linked
to several diseases (Burkitt et al., 1972; Sonnenburg and
Sonnenburg, 2014). Fiber provides direct physical benefits,
including increased fecal bulking and laxation (Burkitt et al.,
1972). However, another feature of dietary fiber—a nutrient cate-Cgory that includes a broad array of polysaccharides that are not
digestible by human enzymes—has also drawn it into the spot-
light: it provides an important substrate to the community of
microbes (microbiota) that inhabits the distal gut (Sonnenburg
and Sonnenburg, 2014). Unlike humans, who produce 17
gastrointestinal enzymes to digest mostly starch, our gut micro-
biota produces thousands of complementary enzymes with
diverse specificities, enabling them to depolymerize and ferment
dietary polysaccharides into host-absorbable short-chain fatty
acids (SCFAs) (El Kaoutari et al., 2013). Thus, the physiology of
the gut microbiota is geared toward dietary polysaccharide
metabolism. At present, relatively little is known about how a
fiber-deprived gut microbiota fulfils its energy demands and
how low fiber-induced microbiota changes impact our health.
Apart from dietary fiber, an alternative energy source for the
microbiota is the glycoprotein-rich mucus layer that overlies
the gut epithelium as a first line of defense against both
commensal microbes and invading pathogens (Johansson
et al., 2013; McGuckin et al., 2011). The colonic mucus layer is
a dynamic and chemically complex barrier composed largely
of secreted mucin-2 glycoprotein (MUC2) (Johansson et al.,
2008). Goblet cells secrete MUC2 as a disulfide cross-linked
network that expands to form an inner layer, which is tightly
adherent to the epithelium and is poorly colonized by
commensal bacteria. As bacterial and host enzymes continu-
ously hydrolyze the luminal edge of this layer, a looser outer layer
is formed that supports a more dense and metabolically distinct
community (Li et al., 2015). A key nutritional aspect of the mucus
layer for gut bacteria is its high polysaccharide content, with up
to 80% of the mucin biomass being composed of mostly
O-linked glycans (Johansson et al., 2013). However, only a
distinct subset of gut microbiota species has evolved the capac-
ity to utilize this nutrient source (Hoskins and Boulding, 1981;
Png et al., 2010).
The direct impact of fiber polysaccharides on the microbiota,
combined with the ability of at least one nutritional generalistell 167, 1339–1353, November 17, 2016 ª 2016 Elsevier Inc. 1339
(Bacteroides thetaiotaomicron) to shift from dietary polysaccha-
rides to mucus glycan metabolism in the absence of fiber (Son-
nenburg et al., 2005), suggests a connection between diet and
the status of the colonic mucus barrier. Indeed, three previous
reports have correlated reduced dietary fiber with thinner colonic
mucus (Brownlee et al., 2003; Earle et al., 2015; Hedemann et al.,
2009). Nevertheless, the underlying mechanisms with respect to
involvement of the microbiota and, perhaps more importantly,
consequences for the host remain largely unknown. Such knowl-
edge is important as it could provide explanations for why devi-
ations or imbalances in gut microbial community membership
and physiology (‘‘dysbiosis’’) correlate with several negative
health outcomes, including pathogen susceptibility, inflamma-
tory bowel disease (IBD), and colon cancer (Cameron and Sper-
andio, 2015; Flint et al., 2012; McKenney and Pamer, 2015).
Finally, such knowledge could inform therapeutic and preventa-
tive strategies to correct these conditions.
The integrity of the mucus layer is critical for health. Genetic
ablation of Muc2 in mice brings bacteria into close contact
with the epithelium, leading to inflammation and colon cancer
(Van der Sluis et al., 2006). Additional studies have implicated
reduced or abnormal mucus production or O-glycosylation in
the development of intestinal inflammation (Fu et al., 2011; Lars-
son et al., 2011) and penetration of commensal bacteria in the
inner mucus layer in murine models of colitis and ulcerative
colitis patients (Johansson et al., 2014). Moreover, the mucus
barrier—a reservoir of antimicrobial peptides and immunoglobu-
lins—is the first structure that a mucosal pathogen must
overcome to establish an infection (McGuckin et al., 2011).
Given that the status of the mucus layer is precariously balanced
between replenishment by goblet cells and degradation by gut
bacteria, we hypothesized that a fiber-deprived microbiota
would progressively forage on this barrier, leading to inflamma-
tion and/or increased pathogen susceptibility.
We aimed to investigate the mechanistic connections be-
tween chronic or intermittent dietary fiber deprivation on micro-
biota composition and physiology as well as the resulting effects
on themucus barrier. To create amodel that facilitates functional
interpretation, we assembled a synthetic gut microbiota from
fully sequenced human gut bacteria in gnotobiotic mice. In the
face of reduced dietary fiber, we examined changes in commu-
nity physiology and susceptibility to Citrobacter rodentium, a
murine pathogen that models human enteric E. coli infection
(Collins et al., 2014). We demonstrate that a microbiota deprived
of dietary fiber damages the colonicmucus barrier and promotes
pathogen susceptibility. Our findings suggest a mechanism
through which diet alters the activity of the gut microbiota
and impacts health, which is important prerequisite knowledge
for rationally designing future dietary interventions and
therapeutics.
RESULTS
A Synthetic Human Gut Microbiota with Versatile Fiber
Polysaccharide Degrading Capacity
Diet changes are known to rapidly affect the composition of the
microbiota in humans and rodents (David et al., 2014; Faith et al.,
2011; McNulty et al., 2013; Rey et al., 2013). However, the full1340 Cell 167, 1339–1353, November 17, 2016complexity of the gut microbiota is a barrier to deriving detailed
conclusions because sequence-based approaches (16S rRNA
gene and meta-genomics/-transcriptomics) suffer from sub-
stantial functional uncertainty. Thus, to test our hypothesis that
specific members within a fiber-deprived gut microbiota cause
damage by increasingly foraging for nutrients in the protective
mucus layer, we designed a synthetic microbiota (SM) contain-
ing 14 species of fully sequenced commensal human gut bac-
teria (Figure 1A). The selected species were chosen to represent
the five dominant phyla and collectively possess important core
metabolic capabilities (Figure S1A).
To provide an additional layer of functional knowledge about
complex carbohydrate metabolism, we pre-evaluated our 14
species for growth in vitro on a panel of 42 plant- and animal-
derived mono- and polysaccharides, including purified mucin
O-glycans (MOGs) as sole carbon sources (Martens et al.,
2011). These growth assays allowed us to determine that all
major groups of dietary fiber and host mucosal polysaccharides
could be used by one ormore strains in our community as well as
which bacteria target each glycan (Figures 1A, S1A, and S1B;
Table S1). It is evident that the four mucin-degrading species
fall into two categories: mucin specialists (A. muciniphila and
B. intestinihominis), which only grow on MOGs as a sole poly-
saccharide source, and mucin generalists (B. thetaiotaomicron
and B. caccae), which each grow on several other polysaccha-
rides. Overall, our choice of species is physiologically and
ecologically representative of the more complex native gut mi-
crobiota. Because our community is composed of bacteria
with determined carbohydrate metabolic abilities, it allows us
to address our central hypothesis in more precise, mechanistic
detail.
To develop a gnotobiotic model, we assembled the SM in
germfree mice, which were fed a standard fiber-rich (FR) labora-
tory diet that contains 15% dietary fiber from minimally pro-
cessed grains and plants (Figures 1B and 1C). Colonized animals
were maintained on the FR diet for 14 days to monitor reproduc-
ibility and stability of community assembly (Figure 1B). All of the
introduced species persisted in each mouse between 6 and 54
or 66 days of colonization depending on the length of the exper-
iment (n = 37 total, two independent experiments; analyzed by
both 16S rRNA sequencing [Table S2] and qPCR approaches
[Table S3]). Individual mice exhibited reproducible SM assembly
irrespective of caging, mouse gender, experimental replicate, or
method of analysis (Figure S2; Tables S2 and S3). In addition to
29 germfree control animals, a total of four different gnotobiotic
colonization experiments (51 SM-colonized mice in total; exper-
iments 14) were performed according to the timeline shown in
Figure 1B.
Both Chronic and Intermittent Fiber Deficiency
Promotes Enrichment of Mucus-Degrading Bacteria
Although dietary changes are known to perturb microbiota
composition, the impact of diet variation, especially chronic or
intermittent fiber deficiency, on the activities and abundance of
mucin-degrading bacterial communities has not been studied
in functional detail. After validating stable SM colonization, three
groups of mice were maintained by constant feeding of one of
three different diets: fiber-rich (FR), fiber-free (FF), or prebiotic
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Figure 1. Carbohydrate Utilization by the Synthetic Human Gut Microbiota Members and Gnotobiotic Mouse Treatments
(A) Heatmap showing normalized growth values of 13/14 synthetic human gut microbiota (SM) members.
(B) Schematic of the gnotobiotic mouse model illustrating the timeline of colonization, feeding strategies, and fecal sampling.
(C) Compositions of the three distinct diets employed in this study (common additives such as vitamins and minerals are not shown). The prebiotic mix contained
equal proportions of 14 host indigestible polysaccharides (see Table S1).
See also Figure S1.(Pre). In contrast to the FR diet that contained naturally milled
food ingredients with intact fiber particles, the Pre diet was
designed to study the effect of adding a mixture of purified,
soluble glycans, similar to those used in prebiotic formulations
(Figure 2C). To imitate the fact that the human diet experiences
fluctuating amounts of fiber from meal-to-meal, four other
groups were alternated between the FR and FF or Pre and FF
diets on a daily or 4-day basis (Figure 1B).
Fecal microbial community dynamics showed that in mice
switched to the FF diet, several species rapidly and reproducibly
changed in abundance (Figures 2A, 2B and S3). Four species—
A.muciniphila, B. caccae, B. ovatus, and E. rectale—were highly
responsive to diet change. A.muciniphila and B. caccae are able
to degrade MOGs in vitro. B. ovatus and E. rectale cannot
metabolize MOGs, but together can use a broad range of poly-
saccharides found in dietary fiber (Figure 1A). In the absence
of fiber, the abundance of A. muciniphila and B. caccae
increased rapidly with a corresponding decrease of the fiber-de-
grading species (Figure 2A). The Pre diet, which contains purified
polysaccharides and is otherwise isocaloric with the FF diet, hada similar effect on community composition as the FF diet but
separated slightly by PCoA ordination from FF, likely due to
increased Bacteroides abundance (Figures 2A and 2B). Intrigu-
ingly, the abundances of the same four bacteria noted above
fluctuated rapidly on a daily basis when the FR and FF diets
were oscillated (Figures 2C and S3), corroborating their ability
to respond dynamically to variations in dietary fiber. The increase
in mucin-degrading species observed in fecal samples matched
with cecal abundances at the end of the experiment (Figure 2D
and panels to the right of plots in Figure 2A). Moreover, similar
levels of mucin-degrading bacteria were quantified in the colonic
lumen andmucus layer using laser capture microdissection (Fig-
ure 2E), indicating that proliferation of mucin-degrading bacteria
in this model is a community-wide effect and not limited just to
the mucus layer.
Many of the other bacteria (except R. intestinalis and B. intes-
tinihominis) were sensitive to changes between the FR and FF
diets on daily and 4-day bases, albeit to lower degrees (Fig-
ure S3B; Table S2). Two additional species especially sensitive
to diet change were Desulfovibrio piger (increased on FF diet)Cell 167, 1339–1353, November 17, 2016 1341
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Figure 2. Complex Dietary Fiber Deficiency Leads to Proliferation of Mucus-Degrading Bacteria
(A) Stream plots exhibiting fecal (over time, Figure 1B) and cecal (end point) microbial community dynamics and average abundance of total species-specific
transcripts from cecal RNA-seq transcriptome mapping at the endpoint; for transcript abundance n = 3 mice/group.
(B) Principal coordinate analysis (PCoA) based on bacterial community similarity.
(C) Changes in relative bacterial abundance over time in mice oscillated for 1-day increments between FR and FF feeding. Changes in FR and FF control groups
are shown for comparison. Asterisks (colored according to the dietary group) indicate a statistically significant difference in the change of relative abundance from
the previous day within each group. Student’s t test.
(legend continued on next page)
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and Marvinbryantia formatexigens (decreased on FF diet) (Fig-
ure S3A). Population changes in the groups oscillated between
Pre and FF diets were similar to the abundances observed in
FF only diet regimen (Table S2). Thus, despite the pure polysac-
charides contained in the Pre diet exerting a clear physiological
impact on the microbiota (discussed below), the amount and
composition of the purified polysaccharides in this diet exert little
effect on species composition.
Community Transcriptional and Enzymatic Readouts
Demonstrate Enhanced Degradation of Mucus When
Fiber Is Absent
Because mucin-degrading bacteria were higher on both the FF
and Pre diets that lack naturally complex plant fiber, we
reasoned that this increased abundance is due to their ability
to degrade mucus as an alternative nutrient. To test this, we
measured changes in transcripts encoding carbohydrate active
enzymes (CAZymes) that enable gut bacteria to utilize dietary fi-
ber andmucosal polysaccharides (cecal samples from all but the
4-day oscillation groups were analyzed).
Based on new or existing genome annotations of the 14 spe-
cies in our synthetic community, a total of 1,661 different degra-
dative CAZymes belonging to 96 different families were detected
(glycoside hydrolase [GH], polysaccharide lyase [PL], and carbo-
hydrate esterase [CE] families were counted). This number is
close to the total number of families (122) that was identified in
a larger survey of 177 human gut bacterial reference genomes
(El Kaoutari et al., 2013), indicating that our synthetic community
retains much of the metabolic potential toward carbohydrates
that is present in a more diverse microbiota. Of the 96 enzyme
families in our community, members of 38 families, plus M60-
like proteases (pfam13402), a group of enzymes previously
shown to degrade mucin glycoproteins (Nakjang et al., 2012),
showed variable expression in either FR/FF or Pre/FF community
transcriptome comparisons (Figure 3A). These differentially
abundant degradative enzymes mapped to 770 different genes
contributed from all species except D. piger (Table S4).
Our transcriptomic data show that in the mice fed the FR diet,
transcripts belonging to enzyme families that target dietary fiber
polysaccharides were more abundant. In contrast, in mice fed
the FF diet, transcripts encoding enzyme families known to
release sugars from host substrates, including mucinO-glycans,
were elevated (Figure 3A). In line with our in vitro growth assays
(Figure 1A) and the microbial community abundance data
(Figure 2), we found that B. ovatus and E. rectale contributed a
majority of CAZymes specific for plant polysaccharides
(Figure 3A). The four in vitro mucin degraders were the major
contributors to the degradation of host glycans and mucus
in vivo. Additionally, transcripts encoding M60-like proteases
(pfam13402) were also more highly expressed in FF conditions
(Figure 3A). Expression of these putative mucin-targeting en-(D) Additive relative abundances of four mucus-degrading bacteria (Figure 1A).
(E) Relative bacterial abundances in laser capture microdissected colonic lumen
Microbial community abundance data are based on Illumina sequencing of 16S r
bars in (D) and (E) denote interquartile ranges (IQRs). Unless specified, significance
for all other groups. All data in (A)(E) are from experiment 1.
See also Figures S2 and S3 and Tables S2 and S3.zymes was primarily contributed by B. caccae, an organism
that possesses 16 of these genes compared to just four in
A. muciniphila and five in all other species combined. This ob-
servation suggests the tantalizing possibility that B. caccae is
particularly equipped via its M60-like proteases to perform a
key degradative step (cleavage of glycoprotein backbones)
during mucin foraging and this ability may facilitate access to
mucus carbohydrate structures by other bacteria.
In the group fed the Pre diet, similar transcripts as in the FR-fed
group were elevated relative to FF, albeit to lower levels (Fig-
ure 3A bottom histogram). Furthermore, transcripts for the
same bacterial enzymes presumed to target mucus in the
FR/FF diet comparison were observed in the Pre/FF comparison.
Additional RNA sequencing (RNA-seq) analyses of cecal tran-
scriptomes from mice oscillated between FR/FF and Pre/FF on
a daily basis (collected after 1 day on FF diet) provided similar
results to those obtained for the FF only diet mice (Table S4).
Our transcriptomic readouts corroborate the increased abun-
dance of mucin-degrading bacteria observed in these mice (Fig-
ure 2D) and demonstrate that even intermittent fiber deficiency
has the potential to alter themicrobiota and favor mucin-degrad-
ing species.
To further connect the in vivo responses of B. caccae and
A. muciniphila with degradation of mucin O-glycans, we
performed additional transcriptional profiling of these two spe-
cies on purified MOGs from porcine gastric mucus. We have
previously shown that this mixture contains 110 different
structures (Hickey et al., 2015) that when metabolized by
B. thetaiotaomicron stimulate a transcriptional response that
overlaps substantially with genes expressed in vivo under fi-
ber-restricted conditions (Martens et al., 2008). During growth
on MOGs as the sole carbon source, B. caccae and
A. muciniphila activated expression of 82 and 58 genes, respec-
tively (Table S5). Based on a recalculation using a 5-fold cutoff of
previous microarray data from growth in the same substrate,
B. thetaiotaomicron activated expression of 166 genes (Martens
et al., 2008). Next, we examined expression of these validated
O-glycan-responsive genes (for B. caccae, A. muciniphila, and
B. thetaiotaomicron) in the SM community from FF-fed mice
compared to FR. In support of our hypothesis, validated
B. caccae and A. muciniphila O-glycan-responsive genes were
increased in the FF condition (Figure 3B). B. caccae expression
was increased irrespective of normalization by reads mapped
to the whole community (i.e., including increased B. caccae
abundance) or to just the B. caccae genome (discounts abun-
dance change and examines changes in expression).
Consistent with its specialization forO-glycans, A. muciniphila
mostly showed increased expression of O-glycan-responsive
genes proportional to its increased population size (from
20% to 40%), indicating that it does not shift its substrate
utilization in comparison to the FR diet (Figure 3B; see alsoand mucus samples (images displayed on left). n = 3 mice/group.
RNA genes (V4 region) and median values at each time point are shown; error
was determined using Kruskal-Wallis test and n = 4 for FR and FF groups, n = 3
Cell 167, 1339–1353, November 17, 2016 1343
CSu
lfa
tas
e
(m
uc
in)
α-f
uc
os
ida
se
(m
uc
in)
β-N
-ac
ety
lgl
uc
o-
sa
mi
nid
as
e
(m
uc
in)
β-g
luc
os
ida
se
(pl
an
t g
lyc
an
s)
β-x
ylo
sid
as
e
(pl
an
t g
lyc
an
s)
α-g
ala
cto
sid
as
e
(pl
an
t g
lyc
an
s)
1
2
4
8
16
32
64
128
256
FR
FF
Pre
1-day FR/FF
D
FF
FR
0
20
40
60
80
100
120
140
Ac
eta
te
La
cta
te
Su
cc
ina
te
Pr
op
ion
ate
Bu
tyr
ate
0.0
0.5
1.0
1.5
2.0 Butyrate
ns
ns
ns
p=0.0007
ns
SC
FA
s
an
d 
O
A
(m
m
ol
pe
r g
ra
m
 o
f c
ec
al
 c
on
te
nt
s)
A
1
3
5
7
9
11
13
15
17
19
21
Fi
be
r r
ic
h 
(F
R
)/F
ib
er
 fr
ee
 (F
F)
-5
-3
-1
1
3
5
7
9
11
13
P
re
bi
ot
ic
 (P
re
)/F
F
β-X
yl
α-
L-R
ha
βG
al,
α-
L-A
ra
me
thy
l-G
alA
α-
L-R
ha
αG
alA
βG
lu,
βX
yl,
α-
L-A
ra
ac
ety
l-G
alA
, a
ce
tyl
-X
yl
βG
al
ac
ety
l-X
yl
αG
alA
αG
lcA
αG
alA
αM
an
βX
yl,
α-
L-A
ra,
βG
al
βG
lu,
 βX
yl,
 βM
an
, β
Ga
l
αG
lc,
 αG
al,
αG
alA
αM
an
αN
eu
NA
c
αG
alN
Ac
βG
lcN
Ac
βG
lcN
Ac
mu
cin
βG
lc
βM
an
, β
Xy
l
αG
al
βG
al
βG
lu,
 βX
yl
βG
lu
αG
lu
α-
L-R
ha
ac
ety
l-X
yl
ac
ety
l-X
yl
α-
L-R
ha
αG
lu,
 αG
al
βG
lu,
βX
yl,
α-
L-A
ra,
βG
lcN
Ac
βX
yl
αM
anβG
lcN
Ac
Substrate target colors (text over bars):
cellulose & other β-glucans, hemicelluloses
pectins
starch and storage glycans
fungal cell wall mannan
may target multiple polysaccharides
host O- and N-linked glycans
A. muciniphila
C. aerofaciens
E. coli
F. prausnitzii
R. intestinalis
M. formatexigens
C. symbiosum
E. rectale
B. intestinihominis
B. caccae
B. uniformis
B. ovatus
B. thetaiotaomicron
Species color codes (bar colors):
B
0
1
2
3
4
5
6
7
   
   
   
   
   
   
   
Fo
ld
ch
an
ge
m
uc
in
O
-g
ly
ca
n
(M
O
G
)-
sp
ec
ifi
c 
tra
n s
cr
ip
ts
B.
ca
cca
e
(m
uc
us
 ge
ne
ral
ist)
A.
mu
cin
iph
ila
(m
uc
us
 sp
ec
iali
st)
B.
the
tai
ota
o-
mi
cro
n
(m
uc
us
 ge
ne
ral
ist)
FF/FR, normalized
to community
FF/FR, normalized
to single species
Fo
ld
 c
ha
ng
e
Fo
ld
 c
ha
ng
e
GH
98
PL
11
GH
42 CE
8
GH
10
6
PL
10
GH
51
CE
12
GH
53 CE
6
PL
1
GH
11
5
GH
28
GH
76
GH
43 GH
5
GH
4
GH
38
GH
94
GH
26
GH
36 PL
9
GH
30 GH
9
GH
10
5
CE
7
CE
1
GH
31
GH
78
GH
97 GH
3
GH
73
GH
10
GH
12
5
GH
10
9
GH
33
GH
85
GH
84
pfa
m1
34
02
GH
98
PL
11
GH
42 CE
8
GH
10
6
PL
10
GH
51
CE
12
GH
53 CE
6
PL
1
GH
11
5
GH
28
GH
76
GH
43 GH
5
GH
4
GH
38
GH
94
GH
26
GH
36 PL
9
GH
30 GH
9
GH
10
5
CE
7
CE
1
GH
31
GH
78
GH
97 GH
3
GH
73
GH
10
GH
12
5
GH
10
9
GH
33
GH
85
GH
84
pfa
m1
34
02
-5
-3
-1
C
ec
al
m
icr
ob
ia
le
n z
ym
e
a c
tiv
ity
(μ
m
ol
/m
in
/m
g 
of
 p
ro
te
in
)
4-day FR/FF
*
** *
p=
0.
09
**
*
***
***
Fiber targeting enzymes
Mucus targeting 
enzymes
Figure 3. Diet-Specific Changes in Carbohydrate Active Enzyme Expression Reveal a Community Shift from Fiber to Mucus Degradation
(A) Positive and negative fold-changes in transcripts encoding carbohydrate active enzymes (CAZymes) between either FR/FF (top) or Pre/FF (bottom)
comparisons. Only CAZyme families (x axis) in which >2-fold changes and p < 0.05 (Student’s t test) were observed for all of the genes in that family in RPKM-
normalized cecal community transcriptomes are shown as averages; open circles denote statistically insignificant differences. n = 3 mice/group, experiment 1.
(B) Fold-change values of empirically validated (Table S5),MOG-specific transcripts of threemucus-degrading bacteria. n = 3mice/group, experiment 1. Data are
shown as average and error bars represent SEM. Student’s t test.
(legend continued on next page)
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Table S6E). The idea that B. caccae is capable of broader
transcriptional shifts, compared to A. muciniphila, is further
supported by global analysis of its gene expression changes be-
tween the FF and FR diets and 1-day alternations (Figure S4). In
response to the FF diet, B. caccae showed increased in vivo
expression of 230 genes, including 27 degradative enzymes;
whereas, A. muciniphila only showed increased expression of
43 genes, including two enzymes (Figure S4). In contrast to
previous monoassociation data (Sonnenburg et al., 2005),
B. thetaiotaomicron mostly showed unchanged or slightly
decreased expression of its knownO-glycan utilization genes af-
ter a shift to FF (Figure 3B; Table S6B).
Colonic mucin O-glycans contain glycosidic linkages distinct
from plant fibers and also covalently linked sulfate. In further
support of increased bacterial degradation of the host mucus
on the FF diet, we detected significantly increased bacterial en-
zymes targeting mucin linkages (sulfatase and a-fucosidase) in
the mice subjected to the FF diet on either a chronic or intermit-
tent basis (Figure 3C). In contrast, enzymes targeting linkages in
fiber polysaccharides (b-glucosidase) were significantly reduced
in the mice fed the fiber-deficient diets, while others involved in
xylan and a-galactan degradation trended similarly without sig-
nificance (Figure 3C). Despite the dramatic change in microbiota
species abundance and transcriptional response, there was only
one significant change (succinate) in SCFA and organic acids in
the FF diet fed mice (Figure 3D). Overall, the transcriptomic and
enzyme analyses support the conclusion that a fiber-deprived
gut microbiota synergistically and progressively expresses
CAZymes, sulfatases, and proteases to attack mucus polysac-
charides when the diet lacks complex plant fiber.
Fiber Deprivation Leads the Gut Microbiota to Degrade
the Colonic Mucus Barrier
The mucus layer is a dynamic barrier that is constantly replen-
ished through the secretory activity of goblet cells (Johansson
et al., 2013). We rationalized that if bacterial consumption of
mucin-derived nutrients exceeds new production, the integrity
of this critical barrier could be compromised. To explore this
possibility, we performed blinded thickness measurements of
the colonic mucus layer from proximal colon to rectum in each
mouse using Alcian blue-stained sections (Figure 4A). We further
validated thickness of the mucus layer by immunofluorescence
staining of the Muc2 mucins using a-Muc2 antibody (Figure 4B).
To address the possibility that variations in thickness are directly
influenced by the diets used, we measured mucus layer thick-
ness in germfree mice fed the FR or FF diets.
Colonic mucus measurements revealed that mucus thickness
was highest in the colonized group fed the FR diet (Figure 4C). In
most other groups, including germfree (GF) controls, mucus
thickness was significantly thinner than in colonized FR mice.
The observation that GF mice have thinner colonic mucus is
consistent with previous studies in gnotobiotic mice and rats(C) Activities of cecal enzymes determined by employing p-nitrophenyl-linked su
Data are shown as average and error bars represent SD. One-way ANOVA, FR d
(D) Concentrations of organic acid (OA, succinate) and short-chain fatty acids (SC
two independent experiments (#2A and 3). Middle lines indicate average of the in
See also Figure S4 and Tables S4, S5, and S6.(Petersson et al., 2011; Wrzosek et al., 2013), which found that
microbial colonization or exposure to cues such as peptido-
glycan or lipopolysaccharides is required for mucus production.
Notably, mucus in SM-colonized FF diet mice was five to six
times thinner than colonized mice fed the FR diet. From these
data, we conclude that the mucus layer: (1) is initially thinner in
GF mice regardless of diet, (2) begins expanding upon microbial
colonization, but (3) is disproportionately eroded back to a
thinner layer due to the increased mucus foraging activity by
the microbiota in the context of the FF diet. A similar reduction
in mucus thickness was observed in the Pre diet and both
4-day oscillation groups, while an intermediate thickness was
observed in the 1-day FR/FF oscillation group (Figure 4C).
Next, we determined whether mucus production was altered
in colonized mice fed the FF diet. We examined the abundance
of transcripts encoding several key proteins involved in building
and regulating the mucus barrier (Figure 4D):Muc2 andMuc5ac,
two building blocks of colonic mucus; Tff1 and Tff3, goblet cell
proteins that promote mucosal repair and protection; and Klf3,
a transcription factor involved in barrier function. Our results
show that the transcription of the major colonic mucin gene
(Muc2) was slightly elevated in the colonized FF diet group, sug-
gesting a compensatory response of the host to offset the
increased bacterial mucus degradation in this group; whereas
other genes (Muc5ac, Tff1, Tff3, and Klf3) remained statistically
unchanged (Figure 4D). Qualitative visualization by Alcian blue
(Figure 4A) staining supports the conclusion that the colonic tis-
sue of FF-fed colonized mice contained similar numbers of
goblet cells that have yet to secrete their glycoproteins.
As expected, degradation of the mucus layer by the fiber-
deprived gutmicrobiota brought luminal bacteria closer to the in-
testinal epithelium (Figure 4B, inset), which could potentially
trigger deleterious effects or other host compensatory re-
sponses. Histopathology (Figure S5A) and body weight mea-
surements over time (Figure S5B) of mice from the groups with
reduced mucus thickness did not reveal changes compared to
the mice consuming the FR diet. However, measurements of
three additional host parameters provided support for altered
host responses in the face of mucus erosion: the first was fecal
lipocalin—a neutrophil protein that binds bacterial siderophores
and is associated with low-grade inflammation (Chassaing et al.,
2015)—that was increased in the group of colonizedmice fed the
FF diet compared to those fed FR (Figure 4E). A second readout,
colon length, revealed shorter colons in colonized FF fed mice
and other SM colonized groups when compared to colonized
FR fedmice or GFmice on either diet (Figure 4F). Additional anal-
ysis of host cecal tissue global transcriptional responses failed to
reveal large-scale changes in the host; although, some compen-
satory responses were suggested by pathway analysis, which
illuminated several immune responses as altered in the colo-
nized FF fed mice (Figures 4G and S5C; Table S7). Collectively,
the data described above indicate that fiber-restricted,bstrates. n = 4 for FR and FF groups and n = 3 for other groups, experiment 1.
iet group versus other groups.
FA) determined from cecal contents. n = 4 mice/group; 2 mice/dietary group in
dividual measurements shown and error bars represent SEM. Student’s t test.
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Figure 4. Microbiota-Mediated Erosion of the Colonic Mucus Barrier and Host Responses
(A) Alcian blue-stained colonic sections showing the mucus layer (arrows). Scale bars, 100 mm. Opposing black arrows with shafts delineate the mucus layer that
was measured and triangular arrowheads point to pre-secretory goblet cells.
(B) Immunofluorescence images of colonic thin sections stained with a-Muc2 antibody and DAPI. Opposing white arrows with shafts delineate the mucus layer.
Inset (FF diet group) shows a higher magnification of bacteria-sized, DAPI-stained particles in closer proximity to host epithelium and even crossing this barrier.
Scale bars, 100 mm; inset, 10 mm.
(C) Blinded colonic mucus layer measurements from Alcian blue-stained sections. Mice in the FR and FF fed colonized groups (experiments 1 and 2A), and in the
FR-diet fed germfree groups are from two independent experiments; all other colonized mice are from experiment 1. Asterisk and dagger indicate that colons of
only two and onemice contained fecal masses, respectively. Data are presented as average and error bars represent SEM. Statistically significant differences are
annotated with different letters p < 0.01. One-way ANOVA with Tukey’s test.
(D) Microarray-derived transcript levels of genes involved in the production of colonic mucus (n = 4 for the FR diet group and n = 3 for the FF diet group). Data are
from two independent experiments (#2A and 3). Values are shown as average and error bars represent SEM. Student’s t test.
(E) Levels of fecal lipocalin (LCN2) measured by ELISA in the FR and FF diet fed groups (day 50, Figure S6A; experiment 2A). n = 7 mice/group. Middle lines
indicate average of the individual measurements shown and error bars represent SEM. Mann-Whitney test.
(F) Colon lengths of mice subjected to different dietary treatments. Data for the FR (with SM) and FF (with SM) are representative of three independent exper-
iments (experiments 1, 2A, and 3). Middle lines indicate average of the individual measurements shown and error bars represent SEM. One-way ANOVA, FR diet
group (with SM) versus other groups.
(legend continued on next page)
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colonized mice experience erosion of the mucus barrier and
some altered intestinal responses, albeit without overt signs of
disease.
A Fiber-Deprived Gut Microbiota Promotes Heightened
Pathogen Susceptibility
Because the mucus layer is a critical barrier against both
commensal microbes and invading pathogens, we next hypoth-
esized that the reduction in thickness associated withmicrobiota
activity during low-fiber conditions would increase pathogen
susceptibility. To test this idea, we chose the attaching/effacing
pathogen Citrobacter rodentium (Cr) because it must traverse
the mucus layer to access the epithelium and cause colitis
(Collins et al., 2014). Toward this point, a previous study demon-
strated that mice genetically lacking the dominant colonic mucin
glycoprotein (Muc2/), but not wild-type mice, develop lethal
colitis following infection with Cr, highlighting that the mucus
layer is an important initial barrier to this pathogen (Bergstrom
et al., 2010).
Therefore, we recreated the previously observed diet-modu-
lated thick and thin mucus layer phenotypes in gnotobiotic
mice and infected both groups with Cr (Figure S6A). To control
for diet-specific effects on Cr pathogenesis in the absence of
our SM, we infected two additional groups consisting of germ-
free (GF) mice fed a priori (4 weeks before infection) the
same FR or FF diets. We collected fecal samples each day
post Cr infection to measure changes in pathogen colonization
by both selective plating for Cr and 16S rRNA gene analysis
(Figures 5A, 5B, and S6A). In the two groups colonized by the
synthetic microbiota, Cr levels gradually increased but were
significantly higher beginning at day 2 in mice fed the FF diet
and remained 10-fold higher thereafter.
The dramatic diet-specific increase of Cr levels in SM-colo-
nized mice fed the FF diet was accompanied by weight loss
that was specific to this group (Figure 5C). Importantly, both
GF+Cr groups that had high pathogen levels (Figure 5A) failed
to exhibit similar weight loss, illuminating that the pathogen alone
is insufficient for this effect on either diet. The higher pathogen
burdens in colonized mice fed the FF diet were associated with
multiple signs of morbidity such as hunched posture and inac-
tivity. Notably, by 10 days post infection, 60% of the mice from
the SM colonized FF group had to be euthanized due to
R20% loss of body weight (Figure 5D). Mice in the other three
groups did not show similar morbidity.
Histological scoring of the cecal and colonic tissue revealed
that the SM-colonized FF diet group experienced inflammation
that covered a significantly more expansive surface area (Figures
5E–5G). An exception was the descending colon/rectum, which
showed larger areas of inflamed tissue in both FR and FF groups;
although, the FF group was still significantly higher and 100%
affected. When the tissue was inflamed, the level of hyperplasia
was similar across all four groups (Figure S6B). Importantly,
there were overall lower levels of inflamed tissue in both of our(G) Changes in the host cecal transcriptome between FR and FF diet conditions.
ingenuity pathway analysis (false discovery rate [FDR] < 0.05 and absolute Log2 fo
are from two independent experiments (#2A and 3).
See also Figure S5 and Table S7.GF+Cr control groups. To determine if increased mucus produc-
tion post infection could explain the lower disease observed in
the GF+Cr groups, we measured thickness of the colonic mucus
and found that Cr triggered only a slight increase in GF mucus
thickness; whereas the thick mucus layer associated with the
FR diet in the context of microbiota colonization persisted (Fig-
ures S7A and S7B).
Based on the above results, we further hypothesized that the
increased area of inflamed tissue in FF mice was due to earlier
and increased pathogen access due to themicrobiota-degraded
mucus layer. To test this idea, we infected the same four treat-
ment groups (SM-colonized or GFmice, fed either FR or FF diets)
with a luciferase-expressing Cr strain (Figure 6A). At 4 days post
infection, we sacrificed all mice and conducted bioluminescent
imaging of the colons after flushing out the luminal contents. In
support of our hypothesis, and despite having similar levels of
fecal Cr in FR- and FF-fed SM mice (Figure 6B), we saw signifi-
cantly higher pathogen signal adherent to the colonic tissue of
SM colonized mice fed the FF diet as compared to those fed
FR (Figures 6C and 6D). The higher levels of attached Cr in FF
fed SM mice were further validated by transmission electron mi-
croscopy, revealing increased appearance of the attaching and
effacing lesions, pedestals and loss of microvilli that is typically
associated with Cr infection (Figure 6E). Notably, GF+Cr mice
on either diet displayed similarly high adherent bacterial signal
as the FF-fed SM mice (Figures 6D and S7C). Taken together,
these results suggest that the pathogen can more quickly tra-
verse the thin colonic mucus layers in GF mice (irrespective of
diet) and SM-colonized mice fed the FF diet. However, the
commensal microbiota is also required in the context of
increased pathogen access to elicit more severe disease,
possibly by provoking co-inflammatory responses.
DISCUSSION
The health benefits of fiber consumption have been purported
for decades, yet the influence of many different chemical and
physical forms of fiber polysaccharides on the gut microbiota
and the ways through which gut bacteria digest, sequester,
and share these chemically complex nutrients, are just now be-
ing unraveled in detail (Cuskin et al., 2015; Rakoff-Nahoum et al.,
2016). Aside from loss of beneficial SCFA production, micro-
biota-mediated mechanisms that connect low fiber intake to
poor gastrointestinal health have not been described. Using a
gnotobiotic mouse model, our study provides a mechanism by
which a diet deficient in complex plant fiber triggers a synthetic
gut microbiota to feed on the colonic mucus layer that acts as a
primary barrier against invading pathogens (Figure 7). Our find-
ings reveal important implications regarding how our immediate
diet history may modify susceptibility to some enteric diseases.
Our approach highlights the power of using a tractable syn-
thetic human gut microbiota, in which the individual members
can be characterized or manipulated to support functionalHeatmap shows statistically significant fold changes of genes identified from
ld-change > 0.5). n = 4 for the FR diet group and n = 3 for the FF diet group; data
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Figure 5. Fiber-Deprived Gut Microbiota Contributes to Lethal Colitis by Citrobacter rodentium
(A) Fecal C. rodentium levels over time. Data are shown as average and error bars represent SEM. Student’s t test; FR (SM+Cr) group versus FF (SM+Cr) group
(bottom statistics labels) and FR (Cr) versus FF (Cr) (top statistics labels). Data in (A)(G) are from experiment 2B.
(B) Relative abundance of C. rodentium in fecal samples over time. Data are shown as median and error bars represent IQR. Wilcoxon test.
(C)Weight changes in the four groups of mice. Values are shown as average and error bars represent SEM. One-way ANOVA, FF diet group (with SM) versus other
groups.
(D) Survival curves for the four groups of mice. One-way ANOVA with Tukey’s test.
(E) Representative images of unflushed ceca after H&E staining highlighting major differences in hyperplasia (indicated with arrows in the FR group, where
hyperplasia is patchy and infrequent). Scale bars, 5 mm.
(F) Images of representative H&E-stained colonic thin sections depicting differences in hyperplasia between two groups. Scale bars, low power, 500 mm; high
power, 50 mm.
(G) Measurements of inflamed tissue area in different intestinal segments. n = 5 mice/group except that n = 4 mice were used for FF (SM+Cr) group. Values are
shown as mean and error bars represent SEM. Statistically significant differences are shown with letters within each intestinal segment; p < 0.0002. One-way
ANOVA with Tukey’s test.
See also Figures S6 and S7 and Table S2.
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Figure 6. Fiber-Deprived Gut Microbiota Promotes Faster C. rodentium Access to the Colonic Epithelium
(A) Experimental setup for luminescent C. rodentium experiment (experiment 4).
(B) Fecal burdens ofC. rodentium at 4 dpi. Data are shown as averages and error bars represent SEM; statistically significant differences are shown with different
letters (p < 0.001). One-way ANOVA with Tukey’s test.
(C) Bioluminescence images of flushed colons showing the location and intensity of adherent C. rodentium colonization.
(D) Quantified bioluminescence intensities of C. rodentium from (C) and Figure S7C. Middle lines indicate average of the individual measurements shown.
Kruskal-Wallis one-way ANOVA with Dunn’s test.
(E) Transmission electronmicroscopy images of the representative colonic regions from flushed colons; arrowheads denote individualC. rodentium cells and ‘‘P’’
denotes epithelial pedestals in high power/FF image. Scale bars, low power views 10 mm and high power views 2 mm.
See also Figure S7.interpretations. We demonstrate that fiber deficiency allows the
subset of mucin-degrading bacteria to increase their population
and express mucin-degrading CAZymes to access mucin as a
nutrient. While the ability to annotate CAZyme functions is well
developed vis-a-vis many other metabolic functions that are
important in the microbiome (El Kaoutari et al., 2013), there are
still substantial ambiguities in connecting such predictions withprecise catalytic roles. Here, we not only leverage knowledge
of the substrate and enzyme specificities associated with
some of the well-studied species in our SM (Table S4 and
references therein), but we also employ new in vitro growth
and transcriptional profiling experiments for key mucus-degrad-
ing bacteria (B. caccae and A. muciniphila). Our results point out
a poignant example of how this evolving ‘‘bottom up’’ approachCell 167, 1339–1353, November 17, 2016 1349
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Figure 7. Model of How a Fiber-Deprived
Gut Microbiota Mediates Degradation of
the Colonic Mucus Barrier and Heighted
Pathogen Susceptibility
Schemes derived from results shown in Figures 1,
2, 3, 4, 5, 6 illustrating the balance between fiber
degradation andmucus degradation in FR diet-fed
mice; whereas an FF diet leads to proliferation of
mucus-degrading bacteria and microbiota-me-
diated degradation of the colonic mucus layer.
The latter results in more severe colitis by
C. rodentium.can increasingly resolve functional resolution in complex
microbial systems: only very recently, the single B. ovatus
GH98 enzyme that is increased in the FR diet (leftmost bar,
Figure 3A, top) was shown unequivocally to be an endo-b-xylo-
sidase (Rogowski et al., 2015). Prior to this finding, the GH98
family was only known to contain blood group antigen-cleaving
endo-a-galactosidases—a function that could have confusingly
been associated with mucus O-glycan metabolism instead of its
proper target, the plant fiber xylan.
Our results shed important light on the nature and amount of
fiber that is required for the health of the colonic mucus layer.
The prebiotic diet, which contains purified soluble fibers that
are similar to common prebiotics (e.g., inulin, arabinoxylan,
b-glucan), could not mitigate microbial erosion of the mucus
barrier, despite having a clear impact on the cecal community
transcriptome. Because the FR diet contains complex plant fiber
in its natural form (intact plant cell walls) and at higher concentra-
tion (15% versus 10% in the Pre diet), we cannot determine
which variable (form or amount) is most important. However,
the defined FF diet provides an ideal platform to which purified
polysaccharides and even individual food items can be added
to separately test both of these parameters for their ability to alle-
viate mucus degradation. Such an approach could help to
design dietary therapeutics and next-generation prebiotics and
will be particularly powerful given our existing knowledge of
which polysaccharides the non-mucin-degrading species target
(Figure 1A) and our ability to implant new species with other
defined functionalities in the SM.
The present work highlights that the gut microbiota plays
significant positive and negative roles in the pathogenesis of
C. rodentium. Whereas we previously showed that the pres-
ence of a microbiota blocks colonization by C. rodentium un-
less it possesses virulence traits (Kamada et al., 2012), here,
we demonstrate that diet-specific modulation of the gut micro-
biota can facilitate pathogen colonization and a fiber-deprived
microbiota enhances disease susceptibility. Because the
colonic mucus layer is an early barrier that a pathogen must1350 Cell 167, 1339–1353, November 17, 2016transit (Collins et al., 2014), our data
illustrate that a fiber-deprived microbiota
has profound effects on the susceptibil-
ity to a gastrointestinal pathogen via
reduction of this barrier. The contribution
of mucus degradation to heightened
pathogen susceptibility in our study issurprisingly parallel to a previous report that found a similar
level of lethal colitis in mice with a genetically ablated (Muc2/)
mucus layer (Bergstrom et al., 2010). From this perspective, it is
striking that a dietary alteration in wild-type mice can imitate
the phenotype of a mutation as severe as Muc2 loss. Given
that Muc2 knockout mice experience inflammation and
eventual colorectal cancer, it is reasonable to conclude that
prolonged diet-driven mucus layer loss could result in similar
outcomes. In this context, it is worth noting that higher levels
of mucolytic bacteria have been found in IBD patients (Png
et al., 2010). In light of our observations that mice subjected
to intermittent (daily or 4-day) dietary fiber deprivation exhibit
thinner mucus, it will be critical in future studies to investigate
the impact of periodic fiber deprivation, which is more like
real human dietary habits, on the status of the mucus layer
and the many downstream health effects that may be con-
nected to mucus barrier dysfunction.
Taken together, our findings support a model in which dy-
namic interactions between dietary fiber and metabolism of a
synthetic microbiota composed of commensal bacteria influ-
ence the status of the colonic mucus layer and susceptibility to
pathogens that traverse this barrier (Figure 7). The current find-
ings are likely applicable to gut microbial communities with
higher numbers of species: three previous studies (see also the
Introduction) involving rats with native microbiota and mice
with transplanted human gut microbiota found a correlation be-
tween fiber-deficient diets and thinner colonic mucus layer.
However, it remains to be investigated whether a thin colonic
mucus layer together with a complex microbiota would
contribute to enhanced pathogen susceptibility or how this
effect might vary between individual microbial communities.
Moreover, to understand whether microbial degradation of the
colonic mucus is required for its secretion by the host in order
to achieve a thicker mucus layer, future experiments need to
address the effects on the mucus thickness after exclusion of
the four validated mucus degraders from our synthetic micro-
biota. Finally, because the strains used here are of human origin,
and given the significant structural overlap between human and
murine mucin (including glycosylation) (Johansson et al., 2013)
and that C. rodentium uses similar pathogenesis mechanisms
as human pathogenic E. coli strains, it is likely that such diet-
induced disease susceptibility would extend to humans.
Because E. coli infections are associated with high morbidity
(Kaper et al., 2004) and health-care cost, our study emphasizes
the need to consider a dietary perspective in fully understanding
their transmission. With this in mind, efforts to find the optimal
combinations of natural or prebiotic fiber polysaccharides and
the minimum intake required to restore the integrity and resil-
ience of the colonic mucus layer should be paramount.
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Antibodies
Alexa Fluor 488 goat anti-rabbit IgG Life Technologies Cat#A11008
Mucin 2 antibody (H-300) Santa Cruz Biotechnology Cat#sc-15334
Chemicals, Peptides, and Recombinant Proteins
4-nitrophenyl N-acetyl-b-D-glucosaminide Sigma-Aldrich Cat#N9376
4-nitrophenyl a-D-galactopyranoside Sigma-Aldrich Cat#N0877
4-nitrophenyl b-D-glucopyranoside Sigma-Aldrich Cat#N7006
4-nitrophenol Sigma-Aldrich Cat#73560
Acetic acid Acros Organics Cat#222140010
Adenine Sigma-Aldrich Cat#A2786
Alanine Sigma-Aldrich Cat#A7469
Alcian blue Sigma-Aldrich Cat#A5268
Alginate Sigma-Aldrich Cat#180947
Ammonium chloride Sigma-Aldrich Cat#A0171
Ammonium sulfate Thermo Fisher Scientific Cat#A702
Arginine Sigma-Aldrich Cat#A8094
Asparagine Sigma-Aldrich Cat#A4159
Aspartic Acid Sigma-Aldrich Cat#A93100
Barley b-glucan (Barliv Betafiber) Cargill Cat#BBF-100
Beef extract Sigma-Aldrich Cat#B4888
Biotin Sigma-Aldrich Cat#B4501
Boric acid Sigma-Aldrich Cat#B6768
Calcium chloride Sigma-Aldrich Cat#C1016
Calcium pantothenate Sigma-Aldrich Cat#P2250
Cellulose International Fiber Corporation Solka-Floc
Chloroform Sigma-Aldrich Cat#496189
Chondroitin sulfate Federal Laboratories Cat#CSP1K
cOmplete, Mini, EDTA-free Protease
Inhibitor Cocktail
Sigma-Aldrich Cat#000000004693159001
Copper(II) sulfate pentahydrate Sigma-Aldrich Cat#C7631
Corn starch / amylopectin Sigma-Aldrich Cat#10120
Cyanocobalamin Sigma-Aldrich Cat#V2876
Cysteine Sigma-Aldrich Cat#C7352
Cytosine Sigma-Aldrich Cat#C3506
DAPI Sigma-Aldrich Cat#D9542
Dextran Sigma-Aldrich Cat#31389
Dipotassium phosphate Thermo Fisher Scientific Cat#BP363-500
EDTA Sigma-Aldrich Cat#ED4SS
Ethanol Decon Labs Cat#2701
Fiber-Free diet Teklad/Envigo Cat#TD.130343
Folic acid Sigma-Aldrich Cat#F7876
Fructose Sigma-Aldrich Cat#F0127
Galactose Sigma-Aldrich Cat#G0625
Glucomannan Konjac Foods Konjac Glucomannan Powder
Glucose Sigma-Aldrich Cat#158968
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Glutamine Sigma-Aldrich Cat#G8540
Glutaraldehyde Electron Microscopy Sciences Cat#16537
Guanine Sigma-Aldrich Cat#G11950
Guar gum galactomannan Sigma-Aldrich Cat#G4129
Glutamic Acid Sigma-Aldrich Cat#G1501
Hematin Sigma-Aldrich Cat#H3281
Histidine Sigma-Aldrich Cat#H8000
Hydrochloric Acid Sigma-Aldrich Cat#320331
Inulin Cargill Oliggo-Fiber Instant Inulin
Iron(II) sulfate heptahydrate Sigma-Aldrich Cat#215422
Isobutyric acid Alfa Aesar Cat#79-31-2
Isoleucine Sigma-Aldrich Cat#I2752
Isopropanol Sigma-Aldrich Cat#278475
Isovaleric acid Alfa Aesar Cat#503-74-2
Laboratory Autoclavable Rodent Diet - 5010 LabDiet Cat#0001326
Larch arabinogalactan Megazyme Cat#P-ARGAL
Leucine Sigma-Aldrich Cat#L8000
Lysine Sigma-Aldrich Cat#L5501
Lysozyme Thermo Fisher Scientific Cat#BP535-1
Magnesium chloride anhydrous Sigma-Aldrich Cat#M8266
Magnesium sulfate anhydrous Sigma-Aldrich Cat#M7506
Magnesium sulfate heptahydrate Sigma-Aldrich Cat#M5921
Manganese(II) sulfate monohydrate Mallinkrodt Cat#6192
Mannose Acros Organics Cat#150600
Menadione Sigma-Aldrich Cat#M5625
Methanol anhydrous Thermo Fisher Scientific Cat#A412-1
Methionine Sigma-Aldrich Cat#M9625
Mucin from porcine stomach Sigma-Aldrich Cat#M1778
N-acetyl glucosamine Sigma-Aldrich Cat#A3286
Nicotinic acid Sigma-Aldrich Cat#N4126
Osmium tetroxide Electron Microscopy Sciences Cat#19100
p-Aminobenzoic acid Sigma-Aldrich Cat#A9878
Pancreatic digest of casein BioWorld Cat#30620060-1
Phenol Sigma-Aldrich Cat#P4557
Phenol:Chloroform:Isoamyl Alcohol
(pH 8.05)
Thermo Fisher Scientific Cat# 15593031
Phenol:Chloroform:Isoamyl Alcohol
(pH 4.3)
Fisher Scientific Cat#BP1754I-400
Phenylalanine Sigma-Aldrich Cat#P2126
p-nitrophenyl a-L-fucopyranoside Sigma-Aldrich Cat#N3628
p-nitrophenyl b-D-xylopyranoside Sigma-Aldrich Cat#N2132
Polygalacturonic acid Sigma-Aldrich Cat#P3850
Potassium 4-nitrophenyl sulfate Sigma-Aldrich Cat#N3877
Potassium chloride Sigma-Aldrich Cat#P9333
Potassium dihydrogen phosphate Thermo Fisher Scientific Cat#P284
Potato pectic galactan Megazyme Cat#P-PGAPT
Proline Sigma-Aldrich Cat#P5607
Propionic acid Acros Organics Cat#149300010
(Continued on next page)
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Propylene oxide Electron Microscopy Sciences Cat#20412
Pyridoxine HCl Sigma-Aldrich Cat#P9755
Resazurin Acros Organics Cat#418900010
Retrievagen A BD Biosciences Cat#550524
Rhamnogalacturonic acid Megazyme Cat#P-RHAM1
Riboflavin Sigma-Aldrich Cat#R7649
RNAprotect QIAGEN Cat#76506
SDS Sigma-Aldrich Cat#L3771
Serine Sigma-Aldrich Cat#84959
Sodium acetate Sigma-Aldrich Cat#S2889
Sodium bicarbonate Sigma-Aldrich Cat#S5761
Sodium chloride Sigma-Aldrich Cat#S7653
Sodium citrate Sigma-Aldrich Cat#S1804
Sodium hydroxide Sigma-Aldrich Cat#S8045
Sodium lactate Thermo Fisher Scientific Cat#S326-500
Sodium molybdate dehydrate JT Baker Chemical Company Cat#3764
Sugar beet arabinan Megazyme Cat#p-ARAB
Tamarind xyloglucan Carbomer Cat#4-00634
Thiamine HCl Sigma-Aldrich Cat#T4625
Thioctic acid Sigma-Aldrich Cat#T5625
Threonine Sigma-Aldrich Cat#T8625
Thymine Sigma-Aldrich Cat#T0895
Tris Thermo Fisher Scientific Cat#BP152
Triton X-100 Sigma-Aldrich Cat#T9284
TRIzol Invitrogen Cat#15596026
Tryptone Thermo Fisher Scientific Cat#BP1421
Tyrosine Sigma-Aldrich Cat#T3754
Uracil Sigma-Aldrich Cat#U1128
Valeric acid Alfa Aesar Cat#109-52-4
Valine Sigma-Aldrich Cat#V0500
Wheat arabinoxylan Megazyme Cat#P-WAXYL
Xylene Sigma-Aldrich Cat#296333
Xylene Substitute Sigma-Aldrich Cat#A5597
Xylose Sigma-Aldrich Cat#X3877
Yeast extract Fluka Analytical Cat#70161
Zinc sulfate heptahydrate JT Baker Chemical Company Cat#4382
Critical Commercial Assays
AccuPrimeTaq DNA Polymerase, high
fidelity kit
Thermo Fisher Scientific Cat#12346086
Affymetrix Mouse Gene ST 2.1 strips Affymetrix Cat#902120
Arcturus PicoPure DNA Extraction Kit Arcturus Cat#KIT0103
DNeasy Blood & Tissue Kit QIAGEN Cat#69506
epMotion 5075 TMX Eppendorf Cat#960020033
High-sensitivity DNA analysis kit Agilent Cat#5067-4626
KAPA SYBRFAST qPCR kit KAPA Biosystems Cat#KK4600
KAPA Library Quantification Kit for Illumina
platforms
KAPA Biosystems Cat# KK4824
Mouse Lipocalin-2/NGAL DuoSet ELISA kit R & D Biosystems Cat#DY1857
(Continued on next page)
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Pierce Microplate BCA Protein Assay Kit Thermo Fisher Scientific Cat#PI23252
PowerSoil Isolation Kit MoBio Laboratories Cat#12888
Qubit RNA Assay Kit Thermo Fisher Scientific Cat#Q32852
Ribo-Zero rRNA Removal Kits (Bacteria) Illumina Cat#MRZB12424
RNeasy Protect Bacteria Mini Kit QIAGEN Cat #74524
SequalPrep Normalization Plate Kit, 96-well Thermo Fisher Scientific Cat#A1051001
TURBO DNase kit Ambion Cat#AM1907
Deposited Data
16S rRNA gene sequences and metadata NCBI BioProjectID; NCBI SRA PRJNA300261;SRP065682
Mouse microarray data NCBI Geo GSM208484955
RNA-Seq data NCBI BioProjectID NCBI: SRP092534, SRP092530,
SRP092478, SRP092476, SRP092461,
SRP092458, SRP092453
Experimental Models: Organisms/Strains
Akkermansia muciniphila: DMS 22959, type
strain
DSMZ Cat#DMS 22959
Bacteroides caccae: DSM 19024, type
strain
DSMZ Cat#DSM 19024
Bacteroides ovatus: DSM 1896, type strain DSMZ Cat#DSM 1896
Bacteroides thetaiotaomicron: DSM 2079,
type strain
DSMZ Cat#DSM 2079
Bacteroides uniformis: ATCC 8492, type
strain
ATCC Cat#ATCC 8492
Barnesiella intestinihominis: YIT11860 DSMZ Cat#DSM 21032
Citrobacter rodentium: DBS100 David Schauer, Massachusetts
Institute of Technology
N/A
Citrobacter rodentium: DBS120 David Schauer, Massachusetts
Institute of Technology
N/A
Clostridium symbiosum: DSM 934, type
strain, 2
DSMZ Cat#DSM 934
Collinsella aerofaciens: DSM 3979, type
strain
DSMZ Cat#DSM 3979
Desulfovibrio piger: ATC 29098, type strain ATCC Cat#ATC 29098
Escherichia coli HS ATCC N/A
Eubacterium rectale: DSM 17629, A1-86 DSMZ Cat#DSM 17629
Faecalibacterium prausnitzii: DSM 17677,
A2-165
DSMZ Cat#DSM 17677
Marvinbryantia formatexigens: DSM 14469,
type strain, I-52
DSMZ Cat#DSM 14469
Roseburia intestinalis: DSM 14610 type
strain, L1-82
DSMZ Cat#DSM 14610
Sequence-Based Reagents
16S rRNA gene Illumina sequencing
primers
Kozich et al., 2013 Table S2B
qPCR primers This paper Table S3A
Software and Algorithms
Arraystar DNAStar http://www.dnastar.com/
t-sub-products-genomics-arraystar.aspx
Gen5 Biotek http://www.biotek.com/products/
microplate_software/gen5_data_
analysis_software.html
(Continued on next page)
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ImageJ Schneider et al., 2012 http://imagej.net/Welcome
Microsoft Excel Microsoft https://products.office.com/en-us/excel
Mothur v1.33.3 Schloss et al., 2009 http://www.mothur.org/
Multi-array average (RMA) method Irizarry et al., 2003 http://www.bioconductor.org/
Prism v5.04 GraphPad Software http://www.graphpad.com/
scientific-software/prism/
QIAGEN’s Ingenuity Pathway Analysis QIAGEN http://www.ingenuity.com/products/ipa
R The R Foundation https://www.r-project.org/
R - Limma package Ritchie et al., 2015 https://bioconductor.org/packages/
release/bioc/html/limma.html
R - Plyr package Wickham, 2011 http://cran.r-project.org/web/packages/
plyr/index.html
UCHIME Edgar et al., 2011 http://drive5.com/usearch/manual/
uchime_algo.html
Other
Acid-washed glass beads (212-300 mm) Sigma-Aldrich Cat#G1277
Anaerobic chamber Coy manufacturing Vinyl Type A + Type B
Biostack automated plate handling device Biotek Instruments BIOSTACK2WR
Bioluminescence reader Xenogen IVIS200
Breathe-Easy polyurethane membrane Biversified Biotech Cat#BEM-1
Flat bottom 96-well plates Costar
General Laboratory Homogenizer Omni International
Microdissection instrument Arcturus Veritas Microdissection Instrument
Millex-GV Syringe Filter Unit, 0.22 mm,
PVDF, 4 mm, ethylene oxide sterilized
EMD Millipore Cat#SLGV004SL
Mini-BeadBeater-16 Biospec Products Cat#607
Powerwave HT absorbance reader Biotek Instruments PowerWaveHT
Synergy HT absorbance reader Biotek Instruments Synergy HT
Upright fluorescence microscope Olympus BX60
Transmission electron microscope Philips Philips CM-100CONTACT FOR REAGENT AND RESOURCE SHARING
Further information may be obtained from the Lead Contact Eric C. Martens (Email: emartens@umich.edu; address: University of
Michigan Medical School, Ann Arbor, Michigan 48109, USA).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Gnotobiotic Mouse Model and Diet Treatments
All animal experiments followed protocols approved by the University of Michigan, University Committee for the Use and Care of
Animals. Germfree male and female wild-type Swiss Webster mice were colonized at 89 weeks of age and none of these mice
were involved in any previous experiments/treatments. Mice were housed alone or in groups as appropriate for gender, litter and
diet requirements and provided ad libitum with autoclaved distilled water and the diets described below.
Identities and culture purity of the bacterial species in the synthetic gut microbiota were confirmed by sequencing their 16S rRNA
genes, followed by comparison to sequences in public databases. Bacteria were grown in their respective media (Table S1) for
community assembly or in vitro growth evaluation on carbohydrates. Each individual bacterial member of the SM was grown anaer-
obically (atmosphere 85%N2, 10%H2, 5% CO2) in its respective medium (Table S1) at 37
Cwith final absorbance (600nm) readings
ranging from about 0.5 to 1.0. Bacterial cultures weremixed in equal volumes and each individual inoculum sealed in its own tubewith
anaerobic headspace. Eachmousewas gavagedwith 0.2mL of thismixture (freshly prepared each day) for three consecutive days at
nearly the same time of the day.
Fiber-free (FF) and Prebiotic (Pre) diets were sterilized by gamma irradiation and the Fiber-rich (FR) diet (LabDiet 5010; autoclav-
able rodent diet) was sterilized by autoclaving. The FF diet was manufactured by Teklad/Envigo (WI, USA) and, as previouslye5 Cell 167, 1339–1353.e1–e12, November 17, 2016
described (TD.140343) (Kamada et al., 2012), consisted of a modified version of Harlan TD.08810 in which starch and maldodextrin
were replaced with glucose. The Pre diet was a new formulation based on the FF diet with 2.1% of a purified polysaccharide mixture
(Table S1) added along with 10% cornstarch (each replacing an equivalent amount of glucose).
On day 14 after colonization (Figure 1B), mice were randomly assigned to groups by a technician, who was not aware of the details
of the treatment groups. The mice were sometimes caged separately even within individual groups. For dietary oscillations, mice
from their respective cage were transferred to a different cage with another diet. Bedding was replaced in each cage before the
mice were transferred. To minimize the potential for circadian effects, the oscillation was carried out at nearly the same time of
the day (±1.0 hr between different days) and fecal samples were collected just prior to their transfer to another cage containing a
different diet. The fecal samples were immediately stored at 20C until further use.
Citrobacter rodentium Infection
Akanamycin (Km)-resistantwild-typeC. rodentium strain (DBS120) anda luciferase-expressing strain ofC. rodentium (DBS100; resis-
tant to ampicillin (Amp)) were used (Kamada et al., 2012). Eachmousewas gavagedwith 0.2mLof culture grown aerobically overnight
at 37C (109 CFU grown in Luria-Bertani broth without antibiotics). The exact same culture was used to gavage all mice in a single
experiment to rule out effects of growth variation on pathogenesis. For experiments with luciferase expressing C. rodentium, mice
were fed the FF diet for nearly the same duration (39 days instead of 42) as for the other experiment (Experiment 2B, Figure 5), prior
to infecting them with C. rodentium. For the experiment with germfree (GF) mice, two groups of mice were separately pre-fed the FR
and FF diets for 4 weeks prior to infection with luciferase-expressing C. rodentium or the wild-type C. rodentium.
Formulation of the Synthetic Microbiota
Weselected 12/14 bacterial species (Figure 1A) from the list of themost common/frequent 7589 species in the human gut (Qin et al.,
2010).Moreover, the selection of 14 species was based in part on carbohydrate utilization abilities of a larger pool of350 strains that
were screened on the same platform as shown in Figure 1A (K. Urs, N.A.P., and E.C.M., unpublished data). Based on the in vitro as-
says, our synthetic microbiota (SM) is not biased toward mucin-degrading bacteria, as only 4/14 species possess this ability
(Figure 1A).
METHOD DETAILS
Experimental Design
A total of four gnotobiotic animal experiments (Experiments 14; also mentioned in figure legends) were performed – details of the
experimental replication are provided in the corresponding figure legends. Both male and female mice were randomly used depend-
ing on the availability of animals. Gnotobiotic Experiment 1 contained 2 male mice in Fiber-rich (FR) group, 2 male mice in Fiber-free
(FF) group and 1male mouse in Prebiotic (Pre) group; all other animals in Gnotobiotic Experiment 1 were females. Gnotobiotic Exper-
iment 2A and 2B had all malemice. All animals in Gnotobiotic Experiment 3 were females. Gender details of the animals in gnotobiotic
Experiment 4 are shown in Figure 6 (both males and females were used). For infection with wild-type C. rodentium in germfree (GF)
mice, all male mice were used. Gender details of GF mice used for infection with luciferase-expressing C. rodentium are included in
Figure S7 (both males and females were used). Finally, all GFmice used for measurement of the colonic mucus layer (Figure 4C) were
females. The researchers were not blinded to the identities of the treatment groups; however, the technician who assigned individual
gnotobiotic animals to different treatment groups was not aware of the experimental details. Measurements of the colonic mucus
layer were single blinded (see details below in the relevant section). The pathologist who devised the inflammation-scoring rubric
was not blinded, and the pathologist who performed the histology scoring and the technician who performed electron microscopy
were blinded for the identities of the treatment groups (see below for details of the methods). No data were excluded from the final
analysis.
Sample size estimations were performed as follows in consultation with a statistician. Based on previous studies it was assumed
an effect size (ratio of mean difference to within group standard deviation) of 3 would be reasonable for readouts such asmucus layer
measurements, enzyme assays and measurement of transcript changes. With 3 animals in each group and a 5% significance level,
two-sided, this would yield a power of 78% for the t test. Therefore, for some of the feeding groups (those alternated between
different diets), 3 animals were used. However, for other feeding groups that were more important for the central research question
of the study (e.g., constant feeding on Fiber-rich (FR) and Fiber-free (FF) diets), at least 4 animals were used to obtain higher power.
For C. rodentium infection experiments, in most cases 5 animals per group were used based on results of our previous study (Ka-
mada et al., 2012).
Sample Processing for Animal Experiments
All animals were killed using CO2 asphyxiation followed by cervical dislocation. The gastrointestinal tracts were quickly removed. The
colons were gently separated, by cutting at the cecum-colon junction and the rectum, and immediately preserved in Carnoy’s fixative
(dry methanol:chloroform:glacial acetic acid in the ratio 60:30:10) with slight modifications to a previous protocol (Johansson and
Hansson, 2012). Note that the Carnoy’s fixative was made fresh with anhydrous methanol, chloroform and glacial acetic acid.
The colons were fixed in Carnoy’s solution for 3 hr followed by transfer to fresh Carnoy’s solution for 23 hr. The colons wereCell 167, 1339–1353.e1–e12, November 17, 2016 e6
then washed in dry methanol for 2 hr, placed in cassettes and stored in fresh dry methanol at 4C until further use. Cecal contents
from each animal were divided into replicates; instantly flash-frozen in liquid nitrogen and were stored at 80C until further use.
Immediately after squeezing out the cecal contents, the cecal tissues were transferred in separate screw-cap tubes and were rapidly
flash-frozen in liquid nitrogen, followed by their storage at 80C until further use. Lengths of colons were measured immediately
after fixation in Carnoy’s solution by photographing the colons in a reference cassette of identical size, followed by length measure-
ment in ImageJ.
Purification of Mucin O-Glycans
Mucin O-glycans were purified from porcine gastric mucus as previously described in Martens et al. (2008), albeit with several
modifications. Porcine gastric mucin (Type III, Sigma, USA) was suspended at 2.5% w/v in 100 mM Tris (pH 7.4): the mixture was
immediately autoclaved for 5 min to increase solubility and reduce potential contaminating glycoside hydrolase and polysaccharide
lyase activity, then cooled to 55C. Proteinase K (Invitrogen, USA) was added to a final concentration of 0.1 mg/ml and the suspen-
sion was incubated at 55C for 1620 hr with slow shaking. The proteolyzed solution was subsequently centrifuged at 21,000 x g for
30 min at 4C to remove insoluble material, and NaOH and NaBH4 were added to final concentrations of 0.1 M and 1M, respectively.
This solution was incubated at 65C for 18 hr to promote selective release of O-linked glycans (mucin O-glycans and GAGs) from
mucin glycopeptides by alkaline b-elimination. The pH was subsequently decreased to 7.0 with HCl and the neutralized mixture
centrifuged at 21,000 x g for 30min at 4C, and then filtered through a 0.22 mmfilter (Millipore) to remove remaining insolublematerial.
The filtrate was exhaustively dialyzed (1 kDa cutoff) against deionized distilled H2O to remove salts and contaminating small mole-
cules. The collected mucosal glycans were further fractionated using anion exchange chromatography by passing them twice over a
DEAE-Sepharose (Sigma) column (325mLbed volume; equilibrated in 50mMTris 7.4; gravity flow). The flow through (neutral fraction)
was collected and the columnwashedwith 1L of 50mMTris, pH 7.4. This fraction was used in all growth experiments andwas further
prepared by dialyzing against ddH2O (1 kDa cutoff), lyophilized and resuspended in ddH2O at 20 mg/ml.
Bacterial Growth Assays in a Custom Carbohydrate Array
All species except Desulfovibrio piger were evaluated in a custom carbohydrate array (n = 2 replicate cultures per glycan); D. piger
failed to grow in any of the tested minimal media, but is not predicted to have extensive carbohydrate-degrading capacity based on
its small genomic complement of only 30 carbohydrate active enzymes. The custom carbohydrate array was formulated according to
Martens et al., 2011, but with a few modifications included in the following protocol: flat bottom 96-well plates (Costar) were used, to
which 100 mL of a 2x concentrated solution (prepared in Milli-Q water) of each of the sterilized carbohydrate stocks (Table S1) were
added. The plates were then transferred to the anaerobic chamber (10% H2, 5% CO2 and 85% N2) and were allowed to equilibrate
with the anaerobic atmosphere for34 hr. Growth assays for all carbohydrates were carried out in non-adjacent duplicates and all
growth arrays contained two non-adjacent water only negative controls that were checked to ascertain that other medium compo-
nents without added carbohydrates did not yield detectable growth. The cultures for the inoculation were grown overnight in their
respective minimal media (MM)/regular growth media at 37C under an anaerobic atmosphere (10% H2, 5% CO2 and 85% N2).
MM for some bacterial species were used from previous studies, and for other members of the synthetic microbiota, MM with novel
formulations were devised (see Table S1 for compositions of all growth media used in this study). MMwere pre-reduced in the anaer-
obic chamber overnight by loosening the lids of the glass bottles containing the MM. 1 mL of the culture was centrifuged and the
pellet was recovered – note that the centrifugation was performed inside the anaerobic chamber. The pellet was washed 2 times
in the respective MM in order to remove carried over carbohydrates from the culture media and was then resuspended in 1 ml,
2x concentrated MM without any carbohydrates. This 1 mL culture was used to inoculate 50 mL of 2x concentrated MM without
carbohydrates at a 1:50 ratio. 100 mL of the resulting cultures were then added to the individual wells of the carbohydrate solutions
in the 96-well plates, resulting in 200 mL of final volumes. A gas permeable, optically clear polyurethane membrane (Diversified
Biotech, USA) was then used to seal the well plates under the same anaerobic atmosphere. Next, the well plates were loaded in
a Biostack automated plate-handling device (Biotek Instruments, USA) placed inside the anaerobic chamber, which was coupled
with a Powerwave HT absorbance reader (Biotek Instruments, USA).
Absorbance values were measured at 600nm (A600) at an interval of 10 min over 96 hr for all species, except for Akkermansia
muciniphila, for which the absorbance was measured over 144 hr, owing to its relatively slow growth on mucin O-glycans
(Figure S1B). To construct the heatmap containing relative growth values (Figure 1A), absorbance data of all bacterial species
were normalized as follows: only carbohydrate growth assays for which both replicate cultures produced an increase in absorbance
of more than 0.1 were scored as positive (all other values were set to 0). Next, the maximum change in absorbance was normalized
within each individual species by setting its best growth to 1.0 and normalizing all other positive growths to this maximum value
(normalized values were thus between 0 and 1.0). Finally, growth on each substrate was normalized across species by setting the
maximum (previously normalized) growth value on that substrate to 1.0 and then adjusting the growth values for other strains on
that same substrate relative to the maximum value, yielding final normalized values between 0 and 1.0. Both raw and normalized
values are provided in Table S1.
To perform RNA-Seq analysis on pure cultures, A.muciniphila and Bacteroides caccae were grown anaerobically in their respec-
tive minimal media (Table S1). A. muciniphila was grown separately on two different substrates N-acetylglucosamine (5 mg/ml final
concentration) and purified mucinO-glycans (10 mg/ml final concentration). Cultures of A.muciniphila were grown to mid-log phasee7 Cell 167, 1339–1353.e1–e12, November 17, 2016
(A600 values between 0.450.6). Cultures ofB. caccaewere grown separately on glucose andmucinO-glycan as the carbon sources
(10 mg/ml final concentration for both sugars) to mid-log phase (OD values between 0.70.8). Cultures of both species were treated
with RNAprotect (QIAGEN, USA) according to the manufacturer’s instructions. The RNAprotect treated bacterial pellets were stored
at 80C until extraction of RNA. Two replicate cultures per glycan (with closely matching ODs) were performed for each of the two
bacterial species.
Citrobacter rodentium quantification
To determine the CFUs ofC. rodentium, freshly collected fecal samples were weighed and homogenized in cold phosphate-buffered
saline andwere plated on LB agar plates with 50 mg/ml Km (for strain DBS120) or 200 mg/ml Amp (for strain DBS100) at serial dilutions
up to 109. The plates were incubated aerobically overnight at 37C. Killing of E. coli HS, the only facultative anaerobe in our SM, to
Km and Amp was confirmed by plating it on LB agar with Km or Amp.
Extraction of Nucleic Acids
DNA from fecal samples was isolated using the MoBio PowerSoil Isolation Kit (MoBio Laboratories, USA) adapted for use in the ep-
Motion 5075 TMX or the DNA extraction protocol used for Collinsella aerofaciens (mentioned below). DNA was extracted from the
bacterial pure cultures using DNeasy Blood & Tissue Kit (QIAGEN, USA), except that the following bead beating and phenolchloro-
form extraction protocol, was employed to better extract DNA fromC. aerofaciens: 12mL of the overnight grown culture was centri-
fuged and the resulting pellet was combined with acid-washed glass beads (212300 mm; Sigma-Aldrich, USA), 500 ml Buffer A
(200 mM NaCl, 200 mM Tris, 20 mM EDTA), 210 ml SDS (20% w/v, filter-sterilized) and 500 ml phenol:chloroform:isoamyl alcohol
(25:24:1, pH 8.05; Thermo Fisher Scientific, USA). A Mini-BeadBeater-16 (Biospec Products, USA) was used to disrupt the bacterial
cells for 5min at room temperature, whichwas followed by cooling the samples for 12min onwet ice. The samples were then centri-
fuged and the aqueous phase was recovered. An equal volume of phenol:chloroform:isoamyl alcohol (25:24:1) was added to the
aqueous phase and was mixed with the aqueous phase by gentle inversion. After centrifugation (12,000 rpm, 4C, 3 min), the
aqueous phase was recovered. Next, 500 ml of pure chloroform was added to the aqueous phase, mixed by inversion and the tubes
were centrifuged (12,000 rpm, 4C, 3 min). The aqueous phase was transferred into fresh tubes and 1 volume of20C chilled 100%
isopropanol and 1/10 volume 3 M sodium acetate (pH 5.2) were added to the aqueous phase. The samples were mixed by gentle
inversion and incubated at20C for 1 hr, centrifuged for 20min (12,000 rpm, 4C) and the supernatants were discarded. The pellets
were washed in 70% ethanol (v/v, prepared in nuclease-free water), air-dried and then resuspended in nuclease-free water. The
resulting DNA extracts were purified by using DNeasy Blood & Tissue Kit (QIAGEN, USA).
RNAwas extracted from cecal contents using a standard phenolchloroformmethodwith bead beating asmentioned earlier (Son-
nenburg et al., 2006), but with a few modifications: 1 mL of RNAprotect (QIAGEN, USA) stored at room temperature was added to
200300 mg of cecal contents stored at 80C, followed by thawing the cecal samples on wet ice. After the cecal contents were
thawed, 250 ml acid-washed glass beads (212300 mm; Sigma-Aldrich, USA) were added to the samples. Next, 500 ml of a solution
of Buffer A (200 mM NaCl, 200 mM Tris, 20 mM EDTA), 210 ml of 20% SDS (filter sterilized) and 500 ml of phenol:chloroform:isoamyl
alcohol (125:24:1, pH 4.3; Fischer Scientific, USA) were added to the samples. The mixture was then bead beaten (instrument same
as above) for 5 min and centrifuged at 4C (3 min at 13000 rpm). The aqueous phase was recovered and mixed with 500 ml of the
aforementioned phenol:chloroform:isoamyl alcohol solution. Afterward, the mixture was centrifuged again at 4C (3 min at
13,000 rpm) and the aqueous phase was recovered. 1/10 volume of a 3M sodium acetate (pH: 5.2) and 1 volume of 20C chilled
ethanol were added to the aqueous phase. The resulting solution was thenmixed by gentle inversion and incubated for 20min on ice.
Afterward, the mixture was centrifuged at 4C (20 min at 13,000 rpm). The pellet was recovered and washed twice in 500 ml of cold
70% ethanol. The mixture was centrifuged at 4C (5 min at 13,000 rpm) and the RNA pellet was recovered, air-dried and then resus-
pended in nuclease-free water. The RNA extracts were then purified using an RNeasy Mini kit (QIAGEN, USA) according to the man-
ufacturer’s protocol. During extraction of RNA from the cecal contents, a portion (100200 ml) of homogenized material was
removed immediately after bead beating and stored at 80C for extraction of DNA. To extract DNA from these cecal-content
derived samples, DNA extraction protocol described above (used for C. aerofaciens) was used, except that bead beating and inclu-
sion of glass beads were skipped. RNAwas extracted from the RNAprotect-treated cell pellets of bacterial pure cultures ofB. caccae
using RNeasy Protect Bacteria Mini Kit. For extraction of RNA fromRNAprotect-treated cell pellets ofA.muciniphila, the RNA extrac-
tion protocol used for cecal contents (see above) was used, except that the samples were not treated with RNAprotect after thawing.
RNAwas extracted from cecal tissue by thawing the samples in the presence of RNAprotect (as described above for cecal contents),
followed by homogenization (OMNI International) involving metal beads. RNA was then extracted with Trizol (Invitrogen, USA)
according to manufacturer’s instructions. All RNA extracts were subjected to digestion of DNA using TURBO DNase (Ambion,
USA) according to the manufacturer’s instructions.
Bioluminescence Imaging and Transmission Electron Microscopy
For bioluminescence imaging of the luciferase-expressing Citrobacter rodentium, GI tracts were removed and luminal contents were
gently flushedwith a syringe by passing phosphate-buffered saline (PBS) through the colon. The GI tracts were then cut open flat and
rinsed in PBS to remove loosely attached luminal contents. Bioluminescence was visualized (identical exposure across all samples)
and photographed using the IVIS200, Xenogen system. The colonic tissue sections showing highest luciferase intensity (from bothCell 167, 1339–1353.e1–e12, November 17, 2016 e8
Fiber-rich (FR) and Fiber-free (FF) diet fed colonized mice) were then immediately fixed in 2.5% glutaraldehyde prepared in 0.1 M
Sorensen’s buffer (pH 7.4). Thereafter, the samples were treated with 1% osmium tetroxide in 0.1 M Sorensen’s buffer and were
sequentially dehydrated in graded alcohols and propylene oxide, followed by infiltration in Spurrs or Epon. Ultrathin sections of
the tissue samples were made using a diamond knife, stained and were visualized with a transmission electron microscope (Philips
CM-100).
Laser Capture Microdissection
To perform laser capture microdissection (LCM) on colonic thin sections, 4 and 3 fecal masses were analyzed for the Fiber-rich (FR)
and Fiber-free (FF) groups, respectively. Colonic thin sections that were deposited on microscope slides were deparaffinized in
xylene followed by dehydration by isopropanol (see details in the immunofluorescence staining protocol below). The sections
were stored overnight in a container with Drierite dessicant (Drierite, USA). LCM was carried out using a Veritas Microdissection in-
strument (Arcturus, USA). DNA was extracted from the microdissected samples using the Arcturus Pico Pure DNA extraction kit and
the accompanying protocol. In order to perform Ilumina sequencing, 16S rRNA genes were amplified from the LCM-derived samples
using a low biomass-optimized touch down PCR protocol as follows: denaturation at 95C for 2min; a total of 20 cycles with a touch-
down program: denaturation at 95C for 20 s, extension at 72C for 5 min, annealing starting at 60C for 15 s which decreased 0.3C
per cycle; a total of 20 cycles: extension at 72C for 5 min, annealing at 55C 15 s and extension at 72C for 5 min; final extension at
72C for 5 min. Note that a 5 min extension was used in order to reduce chimera development. Library preparation and sequencing
were carried out using similar protocols described for fecal and cecal samples (see below).
Illumina Sequencing and Data Analysis
PCR and library preparation were performed by the University of MichiganMicrobial SystemsMolecular Biology Lab as described by
Kozich et al. (2013). The V4 region of the 16S rRNA gene was amplified using the dual-index primers described by Kozich et al. (2013)
with a fewmodifications to the PCR assay, which are included in the following protocol. Each of these dual-index primers contains an
Illumina adaptor, an 8-nt index sequence, a 10-nt pad sequence, a 2-nt linker, and the V4 primers F515 and R806. These primer se-
quences are listed in Table S2. For the PCR assays, 5 mL of each of the 4 mMprimers, 0.15 mLAccuPrimeHigh Fidelity Taq polymerase
(Thermo Fisher Scientific, USA), 2 mL of 10x AccuPrime PCR II buffer (Thermo Fisher Scientific, USA), 11.85 mL of sterile PCR-grade
water and 1 mL of the DNA template were mixed. The PCR cycles started with a 2 min of denaturation at 95C, followed by 30 cycles
each consisting of 95C for 20 s, 55C for 15 s and 72C for 5 min, followed by a final step of 72C for 10 min. The amplicons were
normalized to the lowest concentration of the pooled plates using a SequalPrep normalization plate kit (Thermo Fisher Scientific,
USA). A KAPA Library Quantification kit for Illumina platforms (Kapa Biosystems, USA) was used to determine the library’s concen-
tration and an Agilent Bioanalyzer high-sensitivity DNA analysis kit (Agilent, USA) was employed to determine the amplicon size. The
amplicons were sequenced using an Illumina MiSeq with a MiSeq Reagent 222 kit V2 (Illumina, USA). The libraries were prepared
following the Illumina protocol for 2nM libraries: ‘Preparing Libraries for Sequencing on the MiSeq’ (part 15039740, Rev. D).
Raw sequences were analyzed using mothur (v1.33.3) (Schloss et al., 2009). The following control samples were included: 1) DNA
extracted from the fecal samples collected from germfree mice, 2) a mixture of extracted DNA from pure cultures of the members of
the synthetic microbiota (DNA samples from each strain were mixed in equal amounts) and 3) PBS negative controls during DNA
extraction and PCR amplification. Following sequence barcode-trimming, sequences were aligned to a custom reference database,
consisting of the V4 16S rRNA region from each of the 14 bacterial members andC. rodentium. UCHIME (Edgar et al., 2011) was used
to remove sequence chimeras. The R package ‘vegan’ was used to calculate the principal coordinates analysis (PCoA) from the Bray-
Curtis dissimilarity index based on phylotype classification of the 14 bacterial members. Standard R commands and the R package
‘plyr’ (Wickham, 2011) were used to generatemedian values of relative abundance or change in relative abundance over time, and the
Wilcoxon signed-rank test (two-sample comparisons) or the Kruskal-Wallis test (multiple groups) was used to determine significance
as indicated due to the nonparametric distribution of relative abundance data. Rwas used to visualize relative abundance of bacterial
members in different groups, over time as streamplots, or in heatmaps. Change in relative abundance over time was determined by
subtracting the relative abundance of the specified microbial member from the day prior within each animal, over time. Change in
relative abundance followed a parametric distribution, and Student’s t tests were used to calculate significant differences in the
change of relative abundance between diet groups. The R package ‘ggplots’ was used to generate heatmaps visualizing the Percent
of Maximum Abundance (POMA) as previously described (McNulty et al., 2013). For this, the relative abundance of the different spe-
cies was normalized by their maximum abundance observed for a given species across all time-points from the given animal.
A detailed list of commands used to analyze the data, including the commands used in mothur, are included in https://github.
com/aseekatz/mouse.fiber. Raw sequences have been deposited in the Sequence Read Archive under the study accession and
Bioproject identifiers (SRA: SRP065682 and PRJNA300261).
Microbial RNA-Seq and CAZyme Annotation
Microbial RNA-Seq was performed on pure cultures of A.muciniphila and B. caccae that were grown separately on mucinO-glycans
and on the respective simple sugars (see above). ForBacteroides thetaiotaomicron, gene expression data from previous studies was
utilized (Martens et al., 2008; Sonnenburg et al., 2005). To perform RNA-Seq on cecal samples, 3 samples each (out of 4) were
randomly selected from Fiber-rich (FR) and Fiber-free (FF) diet groups and all three samples each from the Prebiotic diet (Pre), FRFFe9 Cell 167, 1339–1353.e1–e12, November 17, 2016
daily oscillation and PreFF daily oscillation groups were utilized. To remove ribosomal RNA, samples were subjected to Ribo-Zero
rRNA Removal Kits (Bacteria) (Epicenter, Illumina, USA) according to the manufacturer’s instructions. The resulting residual mRNA
concentrations were quantified using Qubit RNA Assay Kit (Life Technologies, USA).
Libray preparation and sequencing of RNA-Seq libraries was carried out using the Illumina HiSeq platform and TruSeq adaptors.
Samples were multiplexed in groups of 24 per lane (see Tables S4, S5, and S6 for quantification of reads mapped to each sample).
The resulting data in fastq file format were demultiplexed and mapped to the respective species genomes or community metage-
nomes using RPKM normalization and default parameters, and were further analyzed for fold-change and statistics (moderated
t test with Benjamini-Hochberg correction) within the Arraystar software package (DNAStar, USA). Mapping reads to all genes in
the 14 species community was intended to retain the contributions of community member abundance shifts while mapping only
to individual genomes was intended to normalize abundance shifts of the same species between conditions and isolate gene expres-
sion changes between conditions. The diet-specific behavior of known B. thetaiotaomicron and B. ovatus genes involved in fiber
polysaccharide degradation (Table S6) was used as internal validation that biologically relevant changes in gene expression were
indeed being detected. As stated above, three biological replicates were analyzed for each of the in vivo dietary conditions used.
p-Nitrophenyl Glycoside-Based Enzyme Assays
p-Nitrophenyl glycoside-based enzyme assays were carried out on cecal samples stored at80C. The cecal samples were thawed
on wet ice and 500 ml buffer (50 mM Tris, 100 mMKCl, 10 mMMgCl2; pH 7.25) was added to 2267 mg of cecal contents. The buffer
additionally contained the following additives: lysozyme (tiny amount of powder/100 mL buffer), TritonX (100 ml, 12%/100 mL buffer),
DNases (tiny amount of powder/100 mL buffer) and protease inhibitor (one tablet of EDTA-free, Protease Inhibitor Cocktail, Roche,
USA/100 mL buffer). After adding the buffer to cecal samples, the samples were sonicated with an ultrasonic processor for 45 s
(9 cycles of 5 s sonication followed by a break of 10 s; 35% amplitude; using a tapered microtip of 3 mm) on ice. Sonicated samples
were subjected to centrifugation (10,000 g, 10 min, 4C). Supernatants (400 ml) were carefully pipetted and were stored at 20C
until further use. The following nitrophenyl-linked substrates (Sigma-Aldrich, USA) were employed: Potassium 4-nitrophenyl sulfate,
4-nitrophenyl a-D-galactopyranoside, 4-nitrophenyl N-acetyl-b-D-glucosaminide, 4-nitrophenyl b-D-glucopyranoside, p-nitro-
phenyl a-L-fucopyranoside and p-nitrophenyl b-D-xylopyranoside. Protein concentrations in the supernatants were determined
using Pierce Microplate BCA Protein Assay Kit (Thermo Scientific, USA). Some samples were diluted with the buffer (same buffer
as above) to obtain a homogeneous range of protein concentrations across all samples. 5 mg of total protein was used in the
150 ml reactions inside flat-bottom, 96-well plates (Costar) with 10 mM nitrophenyl-based substrate in the buffer (same buffer as
above). Absorbance measurements (405 nm) were started immediately in a plate reader (Biotek, USA) at 37C and absorbance
values were recorded every minute for 612 hr duration depending on linearity of the kinetic curve. The enzyme activities were deter-
mined by plotting a standard curve of known concentrations of 4-nitrophenol and measuring the OD values at 37C.
Thickness Measurements of the Colonic Mucus Layer
Post Carnoy’s fixation, the methanol-stored colon samples (see above) were embedded in paraffin and thin sections (5 mm) were
cut and deposited on glass slides. Alcian blue staining was performed by the following protocol: 1) deparaffinization and hydration to
distilled water, 2) Alcian blue solution for 30 min, 3) washing in running tap water for 2 min, 4) rinsing in distilled water, 5) dehydration
with 95% alcohol (2X changes) and treatment with absolute alcohol (2X changes), 3 min each, 6) clearance in xylene (3X changes),
3 min each 7) cover with coverslip. To measure the thickness of the colonic inner mucus layer, thousands of partially overlapping
photographs were taken from nearly the entire length of each colon based from the Alcian blue stained slides after cross-validation
using anti-Muc2 staining (Figures 4A and 4Bmain text). The images captured all of the available fecal masses of all mice, although this
number was variable and there were generally fewer colonic fecal masses in mice fed the FF diet alone or in any combination. Image
sample names were blinded by M.S.D. and M.W., and the thickness of the colonic sections were then measured by E.C.M. using
ImageJ. Only regions in which the mucus layer was sandwiched between epithelium on one side and luminal contents on the other
were used; care was taken to measure regions that represented the average thickness in each blinded image; 23 measurements
per image were taken and averaged over the entire usable colon surface. See Figures 4A and 4B for representative images in which
the region measured as the inner mucus layer is delineated in both Alcian blue and anti-Muc2 staining.
Measurements inCr infected mice were conducted exactly as described for non-infected mice above, with the exception that only
distal colonrectal tissue was considered as this was uniformly a site at which inflammation was high and C. rodentium would be
present. Since only sections in which luminal contents that could be visualized adjacent to the mucus layer were considered, only
a fewmeasurements were obtained for a single SM-colonized infectedmouse fed the FF diet due to the fact that all mice in this group
were extremely morbid and not eating.
qPCR
In addition to Illumina sequencing of the 16S rRNA genes (V4 region), as a second approach to quantifying relative bacterial abun-
dance in fecal samples, phylotype-specific bacterial primers were designed. The primers were designed against randomly selected
genes that were checked for homology against the other 13 species in each case. These primer sequences are listed in Table S3A.
The primers were tested for specificities against the target strain by comparing the primer and target gene sequences against
sequences in public databases. Moreover, specificity of each primer was validated by the following three approaches: 1) byCell 167, 1339–1353.e1–e12, November 17, 2016 e10
quantitative PCR (qPCR) against target species genome andmelting curve analysis (for a single peak), 2) by qPCR for each primer set
against a non-target template comprising of genomic DNA from the 13 bacterial species in our synthetic microbiota, 3) by performing
qPCR against DNA extracted from the fecal samples of germfree mice feeding on the Fiber-rich diet. qPCR was carried out in 384
wells (with each plate including known concentrations of template DNA included to plot a standard curve). The qPCR analyses were
performed using KAPA SYBR FAST qPCR Kits (KAPA Biosystems, USA) on Applied Biosystems (ABI) Real Time PCR instrument
(ABI, USA). The amount of DNA was quantified by plotting a standard curve of varying DNA concentrations of the target template.
Quantification of Short-Chain Fatty Acids
Cecal samples stored at 80C were used to quantify short-chain fatty acids (SCFAs). Samples were first thawed on wet ice. Then,
an equivalent amount of Milli-Q water was added (100 ul per 100 mg of material) to cecal contents (R0.05 g) and the samples were
thoroughly homogenized by vortexing for 1 min. The samples were then centrifuged at 13,000 g for at least 3 min (or for a longer time
depending on time required to obtain a tight pellet). The supernatant was pipetted and filtered through a 0.22 mmfilter (Millex-gv 4mm
SLGV004SL). Samples were kept on ice or frozen until quantification of SCFAs by high-performance liquid chromatography (HPLC).
Some samples were diluted to obtain enough liquid to inject onto the HPLC, or in certain cases they were diluted so that they could
be filtered. A Shimadzu HPLC with an Agilent HP-87X column was utilized for separating compounds, with a mobile phase of
0.01 N H2SO4, a flow rate of 0.6 ml/min, and a column temperature of 50
C. A UV detector set to a wavelength of 214 nm was
used to measure concentrations.
Immunofluorescence Staining
The immunofluorescence staining for Muc2 mucin was performed on the colonic thin sections after several modifications to the pro-
tocols from Johansson and Hansson, 2012 and an immunohistochemistry/tissue section staining protocol from BD Biosciences,
USA (http://www.bdbiosciences.com). The sections were deparaffinized by dipping in 50 mL Falcon conical tubes filled with xylene
(Sigma-Aldrich, USA) for 5 min, followed by transfer to another tube with fresh xylene for 5 min – care was taken to completely
immerse the tissue material in the liquid (also in the subsequent steps). This was followed by two dehydration steps of 5 min each
using 100% isopropanol contained in conical tubes. The slides were then washed by dipping in conical tubes containing Milli-Q
water. The antigens were retrieved by placing the slides in a glass beaker with enough BD Retrievagen A (pH 6.0; BD Biosciences,
USA) to cover the slides. The sections were then heated by microwaving and holding at about 89C for 10 min (microwaving was
repeated during this time, as required). The slides were then cooled for 20 min at room temperature. Afterward, the slides were
washed 3 times with Milli-Q water. Excess liquid was gently blotted away and a PAP pen was used to draw a circle around the tissue
area, in order to better hold liquid on the tissue area during subsequent steps. Blocking was performed by immersing the slides into
blocking buffer (1:10 dilution of goat serum (Sigma, USA) in 1x Tris-buffered Saline (TBS; 500 mM NaCl, 50 mM Tris, pH 7.4)) and
incubating them at room temperature for 1 hr. For the primary antibody staining, the tissue sections were covered in a 1:200 dilution
Mucin 2 antibody (H-300) (original concentration: 200 mg/ml; Santa Cruz Biotechnology, USA) in the aforementioned blocking buffer
and incubated for 2 hr at room temperature. After the incubation step, the excess liquid was blotted away and the slides were rinsed
3 times in 1x TBS (in conical tubes) for 5 min each. The secondary antibody staining was performed by covering the tissue sections
with a 1:200 dilution of Alexa Fluor 488 conjugated goat anti-rabbit IgG antibody (original concentration: 2 mg/ml; Thermo Fisher Sci-
entific, USA) in blocking buffer and the sections were incubated for 1 hr at room temperature in dark. The excess liquid was blotted
away and the sections were rinsed twice for 5 min each using TBS. Next, the sections were stained for 5 min at room temperature in
dark using a 10 mg/ml of DAPI solution diluted in 1x TBS (Sigma-Aldrich, USA). The sections were then rinsed with Milli-Q water and
blotted dry. Finally, the sections were covered with ProLong Gold Antifade Mountant (Invitrogen, USA), covered with coverslips and
the edges of the coverslips sealed with nail polish. The slides were kept at room temperature in dark for at least 24 hr and then visu-
alized by Olympus BX60 upright fluorescence microscope (Olympus, USA).
ELISA for Fecal Lipocalin
Frozen fecal samples (20C) were used to determine the levels of fecal Lipocalin (LCN-2). The assays were performed within
30 days of sample collection. The samples were prepared as mentioned previously (Chassaing et al., 2015), with a fewmodifications
in the sample prepration protocol: fecal samples stored at 20C were thawed on wet ice and 6.967.7 mg of samples were sepa-
rated in fresh tubes, to which 0.5 mL of 1% (v/v) Tween 20 (Sigma-Aldrich, USA) prepared in PBSwas added. To get a homogeneous
suspension, the samples were vortexed for 20 min. The suspension was then centrifuged at 4C for 10 min at 12000 rpm. Next, the
supernatant was carefully recovered and stored at20Cuntil the analysis. Tomeasure the LCN-2 levels, amouse Lipocalin-2/NGAL
DuoSet ELISA kit (R & D Biosystems, USA) was employed and the manufacturer’s protocol was followed.
Tissue Histology
To perform histology analyses on GI tracts of C. rodentium infected mice: first the intestinal segments (cecum and colon together)
were fixed in Carnoy’s fixative for 3 hr, followed by transfer to fresh Carnoy’s fixative overnight. Next, the samples were washed
in 100% methanol (2x) for 30 min each, which was followed by washing in 100% ethanol (2x) for 20 min each. The samples were
then stored in 100% ethanol at 4C until further use. After 100% ethanol washes, the intestinal tissue samples were divided into 3
sections for histology: cecum, ascending colon, and the descending colon/rectum. These sections were embedded, processede11 Cell 167, 1339–1353.e1–e12, November 17, 2016
and cut by an experienced histology core (Washington University, USA), and then stained with hematoxylin and eosin (H and E) prior
to analysis. An unblinded experienced pathologist (T.S.S.) examined the slides from each of the groups to determine a viable readout.
The best readout was determined to be the extent of epithelial area showing crypt hyperplasia. After a scoring rubric was devised, an
independent blinded evaluator (C.A.H.) then measured the total length of each intestinal segment with a ruler in millimeters. Areas of
increased crypt hyperplasia were then determined by microscopy and the lengths of these areas were measured as a percentage of
the total epithelial length on a single slide.
Mouse Microarray Analyses
Mouse microarrays were carried out with Affymetrix Mouse Gene ST 2.1 strips. Expression values for each gene were calculated
using a robustmulti-array average (RMA) approach (Irizarry et al., 2003). Linearmodels were fitted to the data by employing the limma
bioconductor package in R version 3.1.1. Note that selected probesets had a fold change greater than 1.5 and an FDR adjusted
p value of 0.05 or less. Data were analyzed through the use of QIAGEN’s Ingenuity Pathway Analysis (IPA, QIAGEN Redwood
City, http://www.ingenuity.com) using the default parameters. Input data correspond to significantly detected genes with
FDR < 0.05 and absolute log Fold-Change > 0.5. ILK signaling was the number 1 canonical pathway detected (p value =
8.33E-07). TNF targets corresponded to the number 1 (overlap p value = 2.64E-06) upstream regulator detected by IPA. The
category ‘Immune response of cells’ was predicted as the most significantly activated (p value = 6.83E-06 and Z-score = 2.316)
in the inflammatory response category.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical Analyses
All experimental analyses were conducted in consultation with a statistician. Unless otherwise stated in individual method sections
above, all statistical analyses were performed using Prism 5.04 (GraphPad Software, Inc.), except statistics for colony forming units
(CFU) for C. rodentium (Figure 5A) were performed in Excel. Statistically significant differences are shown with asterisks as follows:
*p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001; whereas, ns indicates comparisons that are not significant. Numbers of animals
(n) used for individual experiments, details of the statistical tests used and pooled values for several biological replicates are indicated
in the respective figure legends. A two-tailed t test was employed in all cases. Since generally the microbiome data did not follow a
normal distribution, for these data a nonparametric test such as theWilcoxon test was used. An exception was the data in Figure 2C,
which generally followed a normal distribution and hence a t test was used (see details in the section: Illumina sequencing and data
analysis). For the other data that appeared normally distributed, a t test was used; otherwise, a non-parametric (Mann-Whitney) test
was used (for example for Figure 4E). Finally, ANOVA (parametric) and Kruskal-Wallis (nonparametric) methods were used to
describe differences between more than two groups. For data in Figure 6D, a non-parametric approach with Dunn’s test and
involving pairwise comparisons was employed.
DATA AND SOFTWARE AVAILABILITY
Accession Numbers
Data from this study have been deposited in the NCBI Short-Read Archive (SRA) and Gene Expression Omnibus (GEO) databases
under the following accession and/or BioProjectID identifiers: 16S rRNA gene sequences and metadata (SRA: SRP065682,
PRJNA300261); RNA-seq data (NCBI: SRP092534, SRP092530, SRP092478, SRP092476, SRP092461, SRP092458, SRP092453);
mouse microarray data (GEO: GSM2084849-55). The commands used to analyze the 16S rRNA gene data can be found online at
the following link: https://github.com/aseekatz/mouse.fiber.Cell 167, 1339–1353.e1–e12, November 17, 2016 e12
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Figure S1. Versatile Metabolic Abilities Contributed by Members of the Human Gut Synthetic Microbiota (SM), Related to Figure 1
(A) A schematic displaying abilities of the SM to degrade a wide variety of dietary and host-derived polysaccharides and possible metabolic interactions between
members of the SM. GAGs, Glycosaminoglycans.
(B) Representative growth curves of selected members of the SM on several polysaccharides and glycans as sole carbon sources (n = 2 for each glycan; values
are shown as averages). The absorbance was measured every 10min. See Table S1 for raw and normalized growth values and growth media descriptions for the
13 members of the SM evaluated for carbohydrate growth ability (all except D. piger).
-0.4 -0.2 0.0 0.2 0.4
-0
.4
-0
.2
0.
0
0.
2
0.
4By experiment
PCO 1 (80%)
P
C
O
 2
 (7
%
)
-0.4 -0.2 0.0 0.2 0.4
-0
.4
-0
.2
0.
0
0.
2
0.
4By sex
PCO 1 (80%)
P
C
O
 2
 (7
%
)
Experiment 1
Experiment 2
FR: cage 1
FR: cage 10
FR: cage 11
FR: cage 2
FR: cage 3
FR: cage 4
FR: cage 7
FR: cage 8
FR: cage 9
FF: cage 1
FF: cage 2
FF: cage 5
FF: cage 6
Male
Female
FR: cage 1
FR: cage 10
FR: cage 11
FR: cage 2
FR: cage 3
FR: cage 4
FR: cage 7
FR: cage 8
FR: cage 9
FF: cage 1
FF: cage 2
FF: cage 5
FF: cage 6
FR: Fiber-rich diet
FF: Fiber-free diet 
FR: Fiber-rich diet
FF: Fiber-free diet 
Figure S2. PCoA Plots Demonstrating Clustering of Fecal Bacterial Communities over Time in Two Feeding Regimens, Related to Figure 2
Principal coordinates analysis (PCoA) of microbial community dissimilarity (Bray-Curtis) in fecal samples (collected according to Figure 1B) as determined by 16S
rRNA-based sequencing (V4 region). Samples from both Experiments 1 and 2 are shown, with samples coded by experiment (top panel) or sex (bottom panel) and
by cage (legend) (Experiment 1: n = 4 mice/group; Experiment 2: n = 7 mice/group).
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Figure S3. Fecal Microbial Community Dynamics in Mice from Distinct Dietary Feeding Groups, Related to Figure 2
(A) Relative abundance of indicated bacteria in mice over time subjected to various dietary regimes as determined by Illumina-based 16S rRNA sequencing
(Experiment 1). An explanation for the inverse relationship between the relative abundances of D. piger and M. formatexigens on FR and FF diets is their
(legend continued on next page)
competition for the same electron donor (hydrogen). The increased proliferation of mucin-degrading bacteria in the FF diet indicates higher degradation of
sulfatedmucinO-glycans, which is supported by transcriptomic and enzyme assay data shown in Figure 3. The corresponding release of additional sulfate would
preferentially feed the sulfate-reducer D. piger, leading to production of the toxic metabolite hydrogen sulfide (Figure S1A). Increased D. piger has also been
observed in IBD patients (Gibson et al., 1991; Loubinoux et al., 2002), which could result from enhanced sulfate release bymucinolytic bacteria. Values are shown
as medians ± IQR. n = 4 for FR and FF groups; n = 3 for Pre and 1-day FR/FF groups.
(B) Heatmap showing Percent of Maximum Abundance (POMA) values of all species for two of the feeding groups from Illumina-based sequencing (see Fig-
ure 1B); n = 3 mice/group (Experiment 1; according to timeline in Figure 1B). See also Table S2.
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Figure S4. Dynamic Changes in Transcriptional Profiles of B. caccae and A. muciniphila In Vivo and In Vitro, Related to Figure 3
Figures are based on RNA-Seq measurements of B. caccae (A) and A. muciniphila (B) responses in vitro (minimal mediumwith simple sugars or MOG) and in vivo
(constant feeding or daily alternation of FR and FF diets). In vivo samples are from the entire cecal community at the end of Experiment 1. Gene transcripts that
were increased > 5-fold relative to the corresponding simple sugar references are included for each bacterium. Venn diagrams show overlap and differences of
the transcripts between various groups. Numbers indicate the total differentially regulated gene count for a given sector, while number in parentheses denote
numbers of carbohydrate-degrading enzymes (glycoside hydrolase, polysaccharide lyase or carbohydrate esterase families counted toward this number; sul-
fatases and carbohydrate binding module, CBM, families were not counted). Note that A.muciniphila shows less regulatory versatility as manifest by most of its
upregulated enzymes being confined to the core (dark pink) sector containing all of the in vivo samples. This suggests that MOG only triggers a small percentage
(legend continued on next page)
of this species’ O-glycan degrading responses in vitro; although 8 enzymes were also triggered in vitro. The corresponding histograms display frequencies of
related enzyme families (shownwithmatching colors to their respective Venn sectors). Possiblemucin-related degradative functions are given above each family-
specific histogram bar. For in vitro samples, n = 2 for each MOG and simple sugar grown condition; for in vivo samples, n = 3 mice/group (Experiment 1).
(C) Schematic mucin O-glycan structures, from among 102 that can be found on human and murine Muc2, with the sites at which various enzymes noted in (A)
and (B) would be expected, or are known, to cleave. See also Tables S4 and S5 for in vivo and in vitro transcript data.
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Figure S5. Histology Images, BodyWeights, and Additional Cecal Tissue Transcriptional Responses of Gnotobiotic Mice Fed Fiber-Rich (FR)
and Fiber-Free (FF) Diets, Related to Figure 4
(A) Depictive histology images (Hematoxylin and Eosin of colonic thin sections) showing no overt signs of inflammation between the two dietary regimens
(Experiment 1), in the absence of C. rodentium. Scale bars, 500 mm.
(B) Weight change in mice over time. Values are shown as averages ± SEM; n = 4 for FR and FF groups; and n = 3 for Pre group (Experiment 1). ns, not significant;
One-way ANOVA with Tukey’s test.
(C) Top 15 altered diseases and functions between two dietary regimens detected by Ingenuity Pathway Analysis of microarray data (cecal tissuemRNA). n = 4 for
the FR diet group and n = 3 for the FF diet group (Experiments 2A and 3).
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Figure S6. Microbial Community Structure Pre- and Post-Citrobacter rodentium Infection and Severity of Colitis Post-C. rodentium Infec-
tion, Related to Figure 5
(A) Stream plots illustrating fecal microbial community dynamics over time. Stream plots are based on Illumina sequencing of the V4 region of 16S rRNA genes
(Experiment 2A,B); see Figure 1B for timeline. See Table S2 for % relative abundance of each species in individual mice. Experimental setup for the gnotobiotic
experiments 2A and 2B is also shown.
(B) Histological images illustrating the similar severity of C. rodentium-associated hyperplasia in SM-colonized mice from different feeding groups or germfree
animals only exposed to pathogen. The images are Hematoxylin and Eosin (H and E) stained sections of unflushed cecal tissue all at 10 dpi (Experiment 2B). Scale
bars, 500 mm; higher power inset bars, 50 mm.
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Figure S7. Thickness of the Rectal Mucus Layer Post-Citrobacter rodentium Infection and Bioluminescence Images of Flushed Colons
Showing Colonization Intensity of Luciferase-Expressing C. rodentium, Related to Figures 5 and 6
(A) Periodic acid-Schiff (PAS)-Alcian Blue (AB) stained colonic thin sections showing themucus layer (shownwith opposing arrowswith shafts) in recta of different
groups of mice at 10 dpi (Experiment 2B). Scale bar, 50 mm.
(B) Mucus layer measurements in the recta of mice from PAS-AB stained thin sections (exemplified in A). Asterisk indicates that the FF-SM group had only one
mouse, whose rectal mucus layer could be measured, because the other mice from this group were severely affected with colitis. Data are shown as average ±
SEM; statistically significant differences are shown with different alphabets (p < 0.01); One-way ANOVA with Tukey’s test.
(C) Flushed colons showing intensity of adherent, luciferase-expressing C. rodentium in germ free (GF) mice pre-fed the FR and FF diets and infected with the
pathogen (that is mice without the synthetic microbiota).
